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A B S T R A C T
Background
Convergence insu'iciency is a common binocular vision disorder in which the eyes have a strong tendency to driH outward (exophoria)
with di'iculty turning the eyes inward when reading or doing close work.
Objectives
To assess the comparative e'ectiveness and relative ranking of non-surgical interventions for convergence insu'iciency through a
systematic review and network meta-analysis (NMA).
Search methods
We searched CENTRAL, MEDLINE, Embase, PubMed and three trials registers up to 20 September 2019.
Selection criteria
We included randomized controlled trials (RCTs) examining any form of non-surgical intervention versus placebo, no treatment, sham
treatment, or other non-surgical interventions. Participants were children and adults with symptomatic convergence insu'iciency.
Data collection and analysis
We followed standard Cochrane methodology. We performed NMAs separately for children and adults.
Main results
We included 12 trials (six in children and six in adults) with a total of 1289 participants. Trials evaluated seven interventions: 1) o'ice-based
vergence/accommodative therapy with home reinforcement; 2) home-based pencil/target push-ups; 3) home-based computer vergence/
accommodative therapy; 4) o'ice-based vergence/accommodative therapy alone; 5) placebo vergence/accommodative therapy or other
placebo intervention; 6) prism reading glasses; and 7) placebo reading glasses.
Six RCTs in the pediatric population randomized 968 participants. Of these, the Convergence Insu'iciency Treatment Trial (CITT)
Investigator Group completed four RCTs with 737 participants. All four CITT RCTs were rated at low risk of bias. Diagnostic criteria and
outcome measures were identical or similar among these trials. The four CITT RCTs contributed data to the pediatric NMA, incorporating
interventions 1, 2, 3 and 5. When treatment success was defined by a composite outcome requiring both clinical measures of convergence
to be normal, and also show a pre-specified magnitude of improvement, we found high-certainty evidence that o'ice-based vergence/
accommodative therapy with home reinforcement increases the chance of a successful outcome, compared with home-based computer
vergence/accommodative therapy (risk ratio (RR) 1.96, 95% confidence interval (CI) 1.32 to 2.94), home-based pencil/target push-ups (RR
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2.86, 95% CI 1.82 to 4.35); and placebo (RR 3.04, 95% CI 2.32 to 3.98). However, there may be no evidence of any treatment di'erence
between home-based computer vergence/accommodative therapy and home-based pencil/target push-ups (RR 1.44, 95% CI 0.93 to 2.24;
low-certainty evidence), or between either of the two home-based therapies and placebo therapy, for the outcome of treatment success.
When treatment success was defined as the composite convergence and symptom success outcome, we found moderate-certainty
evidence that participants who received o'ice-based vergence/accommodative therapy with home reinforcement were 5.12 (95% CI 2.01
to 13.07) times more likely to achieve treatment success than those who received placebo therapy. We found low-certainty evidence that
participants who received o'ice-based vergence/accommodative therapy with home reinforcement might be 4.41 (95% CI 1.26 to 15.38)
times more likely to achieve treatment success than those who received home-based pencil push-ups, and 4.65 (95% CI 1.23 to 17.54) times
more likely than those who received home-based computer vergence/accommodative therapy. There was no evidence of any treatment
di'erence between home-based pencil push-ups and home-based computer vergence/accommodative therapy, or between either of the
two home-based therapies and placebo therapy.
One RCT evaluated the e'ectiveness of base-in prism reading glasses in children. When base-in prism reading glasses were compared with
placebo reading glasses, investigators found no evidence of a di'erence in the three outcome measures of near point convergence (NPC),
positive fusional vergence (PFV), or symptom scores measured by the Convergence Insu'iciency Symptom Survey (CISS).
Six RCTs in the adult population randomized 321 participants. We rated only one RCT at low risk of bias. Because not all studies of
adults included composite success data, we could not conduct NMAs for treatment success. We thus were limited to comparing the mean
di'erence (MD) between interventions for improving NPC, PFV, and CISS scores individually using data from three RCTs (107 participants;
interventions 1, 2, 4 and 5). Compared with placebo treatment, o'ice-based vergence accommodative therapy was relatively more e'ective
in improving PFV (MD 16.73, 95% CI 6.96 to 26.60), but there was no evidence of a di'erence for NPC or the CISS score. There was no evidence
of di'erence for any other comparisons for any outcomes. One trial evaluated base-in prism glasses prescribed for near-work activities
and found that the prism glasses group had fewer symptoms compared with the placebo glasses group at three months (MD -8.9, 95% CI
-11.6 to -6.3). The trial found no evidence of a di'erence with this intervention in NPC or PFV.
No adverse e'ects related to study treatments were reported for any of the included studies. Excellent adherence was reported for o'ice-
based vergence/accommodative therapy (96.6% or higher) in two trials. Reported adherence with home-based therapy was less consistent,
with one study reporting decreasing adherence over time (weeks 7 to 12) and lower completion rates with home-based pencil/target push-
ups.
Authors' conclusions
Current research suggests that o'ice-based vergence/accommodative therapy with home reinforcement is more e'ective than home-
based pencil/target push-ups or home-based computer vergence/accommodative therapy for children. In adults, evidence of the
e'ectiveness of various non-surgical interventions is less clear.
P L A I N   L A N G U A G E   S U M M A R Y
How do dierent treatments for the vision disorder, convergence insuiciency, compare in eectiveness?
Why is this question important?
Convergence insu'iciency is a common vision disorder in which a person's eyes tend to driH outwards when they try to use their eyes
together up close. This can cause eye strain, headaches, blurred and double vision. When reading, people with convergence insu'iciency
frequently lose their place or have to re-read text.
There are two main types of treatment for convergence insu'iciency: 1) prism-lensed reading glasses, designed to improve visual comfort,
and 2) eye (vision) therapy designed to restore normal visual function and improve visual comfort.
Di'erent types of vision therapy are prescribed for the treatment of convergence insu'iciency that aim to improve the a'ected person’s
convergence ability (the ability of eyes to turn inwards). Treatment can be self-administered at home using only a pencil (pencil push-
ups) or a computer soHware program (home-based computer therapy). Alternatively, it can consist of a sequence of activities individually
prescribed and monitored by the doctor, administered by trained therapists in an o'ice setting along with practice at home (o'ice-based
therapy with home reinforcement).
We reviewed the evidence from research studies to compare the e'ectiveness of these di'erent treatments (prism reading glasses, o'ice-
based therapy with home reinforcement, and home-based treatments), and also to determine whether the treatments are associated with
adverse (unwanted) e'ects.
How did we identify and evaluate the evidence?
First, we searched the medical literature for randomized controlled studies (clinical studies where people are randomly put into one of
two or more treatment groups). This type of study provides the strongest evidence about the e'ects of a treatment. We compared the
results and summarized the evidence from all the studies. Finally, we assessed how certain the evidence was by considering factors such
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as the way studies were conducted, the number of people in the studies, and the consistency of findings across studies. Based on our
assessments, we categorized the evidence as being of very low-, low-, moderate-, or high-certainty.
What did we find?
We found 12 studies with a total of 1289 people with convergence insu'iciency. Six studies were conducted in children aged seven to 18
years, five studies in young adults aged 15 to 40 years, and one study in adults aged 40 years and older. Studies lasted for between six
weeks and six months.
Results in children
For improving convergence ability, high-certainty evidence showed that o'ice-based therapy with home reinforcement is better than
placebo, home-based computer therapy, and home-based pencil push-ups.
For improving convergence ability, as well as symptoms reported by children (such as headaches or frequent loss of place when reading),
low- to moderate-certainty evidence suggested that o'ice-based therapy with home reinforcement is better than placebo, home-based
computer therapy, and home-based pencil push-ups.
It is not clear (low- to moderate-certainty evidence) whether there is a di'erence for improving convergence alone, or convergence and
symptoms as reported by children, between home-based computer therapy and home-based pencil push-ups, or between these two
home-based treatments and placebo.
One study compared prism reading glasses against placebo reading glasses, and found no evidence of a di'erence in improvement in
convergence or symptoms.
Results in adults
Evidence from three studies indicated that o'ice-based therapy could be more e'ective than placebo for improving convergence when
it was measured one way (‘positive fusional vergence’), but not when measured another way (‘near point convergence’). There was no
di'erence between treatments for changes in symptoms reported by adults.
One study compared glasses with prism lenses against placebo glasses, and found that adults with prism glasses reported fewer symptoms.
However, there was no evidence of a di'erence for improvement in convergence.
Are there any adverse eects from treatment?
No study, in children or adults, reported any adverse e'ects related to study treatments.
What does this mean?
High-certainty evidence indicates that, o'ice-based therapy with home reinforcement is more e'ective than home-based pencil push-ups,
home-based computer therapy, and placebo for treating convergence insu'iciency in children. For adults, the comparative e'ects of these
interventions are less clear.
How-up-to date is this review?
The evidence in this Cochrane Review is current to September 2019.
Interventions for convergence insuiciency: a network meta-analysis (Review)
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B A C K G R O U N D
Description of the condition
Convergence insu'iciency is a common binocular vision disorder in
which the eyes have a strong tendency to driH outward (exophoria),
with di'iculty turning the eyes inward when reading or doing close
work. Because the eyes do not converge adequately, this condition
may lead to symptoms including eye strain, headaches, double
vision, a sense of print moving on the page, frequent loss of place
when reading, inability to concentrate, and short attention span.
Convergence insu'iciency is diagnosed when exophoria is greater
at near than at distance, and the patient has both a remote NPC and
decreased positive fusional vergence.
There is considerable variability in the reported prevalence of
convergence insu'iciency. Estimates of prevalence are based on
samples of elementary, high school, and university students, with
estimates that range from 2.25% to 17.6% (Davis 2016; Hussaindeen
2017; Letourneau 1979; Letourneau 1988; Ma 2018; Porcar 1997;
Rouse 1999; Wajuihian 2015). There is a paucity of data regarding
whether the prevalence of convergence insu'iciency varies by
ethnicity, race, age, sex, geographic location, or socioeconomic
status.
Description of the intervention
Various non-surgical treatments are prescribed for treating
convergence insu'iciency, including base-in prism reading glasses,
home-based convergence therapy (pencil push-ups or near target
push-up therapy), home-based vergence/accommodative therapy
with or without computer soHware, and o'ice-based vergence/
accommodative therapy (Chin 1995; Gallaway 2002; Gri'in 2002;
Grisham 1998; Hugonnier 1969; Pratt-Johnson 2001; Press 1997;
Scheiman 2002a; Scheiman 2002b; von Noorden 1994; von
Noorden 1996). Although surgery and botulinum toxin A injections
are potential treatment options for the less common strabismic
form of convergence insu'iciency, they are rarely used due to the
availability of e'ective non-surgical interventions. These surgical
procedures are not considered in this review. 
Base-in prism reading glasses
There are various methods for determining the amount of prism
to prescribe (Scheiman 2019). In a Convergence Insu'iciency
Treatment Trial (CITT) trial of children nine to 17 years of age
(CITT 2005a), and in the Nabovati 2020 study of young adults,
the investigators prescribed prism based on Sheard's criterion
(Sheard 1930). For convergence insu'iciency, this criterion states
that the magnitude of the prism should be two-thirds of the
exophoria magnitude minus one-third the compensatory near
positive fusional vergence (PFV), i.e. 2/3 (phoria) minus 1/3 (PFV).
Home-based convergence therapy: basic (pencil or target
push-ups)
Home-based convergence therapy is described by Duke-Elder as
follows: "carried out simply by the subject holding a target at arm's
length and then gradually bringing it towards the eye, all the time
maintaining bifoveal fixation" (Duke-Elder 1973). This procedure
should be carried out several times each day for a few minutes.
Placing a target in the background that can be used to monitor
physiological diplopia is oHen recommended (Hugonnier 1969;
Press 1997; Scheiman 2002a; Scheiman 2002b; von Noorden 2001).
Studies surveying the ophthalmic community have suggested
that home-based convergence exercises are the most commonly
prescribed treatment for convergence insu'iciency by both
optometrists and ophthalmologists (Chin 1995; Scheiman 2002a;
Scheiman 2005). However, these surveys were completed more
than 15 years ago, and thus preceded the availability of
comparative e'ectiveness data from RCTs.
In three trials (CITT 2005c; CITT 2008, PEDIG 2016), the home-
based convergence procedure (referred to in the trials as pencil
or target push-ups) used a pencil with 20/60 (6/18) Snellen
optotypes for the target that was slowly brought closer to the
participant's eyes, while the participant attempted to keep the
target single and clear. An index card was placed in the background
so that physiological diplopia awareness could be used to monitor
suppression. Participants were instructed to perform the pencil
push-up procedure 15 minutes per day, five days per week.
Home-based convergence therapy: more intensive
Some clinicians prescribe home-based therapy that is more
intensive than pencil push-ups alone (Scheiman 2002a;
Scheiman 2002b). Additional home-based therapy techniques for
convergence insu'iciency include the use of prism, stereoscopes,
and computer soHware programs designed for vergence/
accommodative therapy (Huston 2015; Nehad 2018; Scheiman
2002a; Scheiman 2005; Serna 2011).
In two trials (CITT 2008, PEDIG 2016), participants in the computer
vergence/accommodative therapy group were prescribed the
aforementioned pencil push-up procedure, as well as therapy
using the Home Therapy System/Computerized Vergence System
(HTS/CVS) computer soHware. Using this therapy program,
participants performed fusional vergence and accommodative
therapy procedures designed to improve convergence and
divergence amplitudes and accommodative ability. Participants
were instructed to do pencil push-ups five minutes per day and use
the HTS/CVS soHware program for 15 minutes per day.
Oice-based vergence/accommodative therapy
O'ice-based vergence/accommodative therapy for convergence
insu'iciency involves a sequence of activities designed to develop
normal and e'icient visual function. It incorporates purposeful,
controlled manipulation of target blur, disparity, and proximity,
with the aim of normalizing the accommodative and vergence
systems and their mutual interactions (Ciu'reda 2002).
In three CITT trials (CITT 2005b; CITT 2008; CITT-ART 2019),
participants in the outpatient (referred to as "o'ice-based" in the
trials) vergence/accommodative therapy group received weekly
60-minute in-o'ice therapy sessions, with additional prescribed
procedures to be performed at home for 15 minutes a day, five
days per week. At each o'ice-based therapy session, participants
performed four to five procedures with supervision and guidance
from a therapist.  The therapist followed a treatment protocol
from the CITT Manual of Procedures, which detailed the sequence
of procedures to be performed, with specifications for length of
time to spend, instructions to be provided to participants, goals,
and criteria for advancing to a more di'icult level or the next
therapy procedure. The Aletaha 2018 study included two o'ice-
based therapy groups. The first consisted of therapy using the
major amblyoscope twice weekly, with home-based therapy (pencil
push-ups) prescribed 15 minutes a day, five days per week. Those
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in the second o'ice-based treatment group performed the same
therapy using the major amblyoscope, supplemented by having the
participants wear -3.00D lenses and base-out prism while reading
or performing near tasks.
Oice-based placebo therapy
In three CITT trials (CITT 2005b; CITT 2008; CITT-ART 2019)
participants in the o'ice-based placebo therapy group received
placebo therapy during a weekly 60-minute o'ice visit and were
prescribed placebo therapy procedures to be performed at home
for 15 minutes per day, five days per week. The placebo procedures
were designed to look like real vergence/accommodative therapy
yet not stimulate vergence, accommodation, or fine saccadic
eye movement skills beyond normal daily visual activities.  The
therapist also followed a detailed protocol from the CITT Manual
of Procedures (accessed at www.optometry.osu.edu/research/
CITT/4363.cfm).
How the intervention might work
The two main categories of intervention for convergence
insu'iciency are base-in reading glasses and convergence therapy.
Convergence therapy can be subdivided into basic home-based
convergence therapy (i.e. pencil or target push-ups), more intensive
home-based vergence/accommodative therapy (e.g. home-based
computer vergence/accommodative therapy), and o'ice-based
vergence/accommodative therapy, as described above.
Patients with convergence insu'iciency are oHen symptomatic
because they have insu'icient convergence ability to compensate
for their exophoria at near. Base-in prism reading glasses are
believed to work by decreasing the amount of compensatory PFV
needed for comfortable vision. While the exact mechanism of how
convergence therapy works is unknown, the hypothesis is that the
resultant increase in PFV ability relieves the symptoms associated
with convergence insu'iciency. In addition, individuals with
symptomatic convergence insu'iciency have abnormal vergence
adaptation, which is the mechanism that allows convergence to
dissociate from accommodation (Schor 1986). Vergence adaptation
has been shown to normalize in convergence insu'iciency patients
aHer vergence/accommodative therapy (North 1982; Brautaset
2006).
The three convergence therapies (home-based pencil or
target push-ups, home-based computer vergence/accommodative
therapy, and o'ice-based vergence/accommodative therapy) di'er
in their 1) ability to control/manipulate stimulus parameters; 2)
dosage; 3) mode of administration (o'ice or home); 4) use of motor
learning theory and patient feedback; and 5) cost.
Controlling/manipulating stimulus parameters
To increase fusional vergence amplitudes a therapy procedure must
either maintain accommodation at the plane of regard and increase
the vergence demand, or maintain vergence at the plane of regard
and increase the stimulus to accommodation (Scheiman 2002b).
There are a variety of available instruments and procedures that
allow manipulation of the stimulus parameters to create various
vergence demands.
The three convergence therapies described above vary significantly
in their ability to allow the manipulation of stimulus parameters.
With home-based convergence exercises, the stimulus is typically
a small letter on a pencil that is moved closer and closer to
the patient's eyes. To maintain single vision, a combination of
proximal, accommodative, and fusional vergence is used with
the accommodative and convergence systems synchronized. In
contrast, o'ice-based vergence/accommodative therapy uses a
wide variety of instrumentation that is designed to improve
the dynamics of the fusional vergence and accommodative
systems, typically using stimuli that require an accommodative
demand di'erent from the vergence demand. Hence, fusional
vergence must be used while proximal and accommodative
vergence are minimized. Fusional vergence is trained separately
and directly, using numerous procedures with varied stimulus
parameters. Home-based convergence exercises using solely
a few procedures such as loose prism and computer-based
vergence/accommodative therapy provide an intermediate level
of manipulation of the vergence/accommodative relationship, but
lack the variety of stimuli available with o'ice-based vergence/
accommodative therapy, as well as therapist feedback.
Dosage
Patients are prescribed procedures to be performed for
approximately the same amount of time at home for all three types
of convergence therapy. However, those undergoing o'ice-based
treatment, also perform an additional 60 minutes per week of
therapy in the doctor's o'ice, resulting in more total therapy time.
Total therapy time prescribed tends to be least with home-based
convergence exercises and the most with o'ice-based vergence/
accommodative therapy.
Mode of administration
For o'ice-based vergence/accommodative therapy, a trained
therapist administers the treatment providing the patient with
feedback regarding performance, attempting to motivate the
patient to make his or her best e'ort, and increasing the di'iculty of
the therapy procedures based on the patient's progress. For the two
home-based convergence therapy approaches, close supervision
from a trained therapist is not available, although parents are
expected to assist younger children with their therapy.
Motor learning principles and patient feedback
Learning is a set of internal processes associated with practice
or experience that result in a relatively permanent change in
responding (Schmidt 1988). These processes are believed to be a
central nervous system phenomenon in which sensory and motor
information is organized and integrated (Aikon 1988; Arbib 1981;
Lisberger 1988) with an ultimate goal of transferring the motor
learning outside of the therapy setting.
For motor learning, numerous variables are considered important
determinants. These include the use of feedback, modeling
and demonstration, transfer of training, part to whole task
practice, variability in practice, and positive reinforcement. Of the
three therapy approaches, o'ice-based vergence/accommodative
therapy uses the principles of motor learning and patient feedback
most frequently and consistently (Birnbaum 1977; Scheiman
2002b).
Changes in underlying neurophysiology
Alvarez and colleagues have used objective recording of vergence
eye movements and functional magnetic resonance imaging
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(fMRI) as outcome measures in studies of participants with
convergence insu'iciency who received vergence/accommodative
therapy (Alvarez 2010; Alvarez 2014, Alvarez 2019). They found
significant changes in functional activity of the vergence neural
circuits between pre- and post-therapy measurements. These data
suggest that post-therapy, there is both an increase in recruitment
of neurons and better synchronization of metabolic demand
from the neurons, specifically in the frontal eye fields and the
oculomotor vermis. Another group that used fMRI as an outcome
measure found that aHer therapy the activation in the occipital lobe
decreased in spatial extent but increased in the posterior, inferior
portion of the occipital lobe (Widmer 2018). These data suggest
that disparity processing for vergence may be enhanced following
vergence/accommodative therapy for convergence insu'iciency.
Why it is important to do this review
While all interventions described in this review are prescribed
for patients with convergence insu'iciency, there is a lack of
consensus among eye care professionals regarding the most
e'ective treatment. One possible reason is that existing trials
made pairwise comparisons of one treatment to another, and
it is di'icult to form a coherent picture of the comparative
e'ectiveness and hierarchy of all interventions using the traditional
pairwise meta-analysis. Because significant di'erences exist in
the time commitment for the patient, number of o'ice visits,
cost, and complexity of the intervention, a systematic review and
network meta-analysis (NMA) is the best approach to synthesizing
the available evidence and providing useful findings to help
clinicians and patients select the most appropriate treatments
for symptomatic convergence insu'iciency. The current review
updates the evidence from an earlier version (Scheiman 2011) and
extends the analysis to incorporate NMA.
O B J E C T I V E S
To assess the comparative e'ectiveness (primary objective) and
relative ranking (secondary objective) of non-surgical interventions
for convergence insu'iciency, through a systematic review and
NMA.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomized controlled trials (RCTs) in this review.
Types of participants
We included trials in which participants had been treated for
convergence insu'iciency using non-surgical interventions. The
definition of convergence insu'iciency varies considerably from
study to study. For this review, we define convergence insu'iciency
as a condition characterized by a larger exophoria at near than at
far, and one or both of the following objective clinical signs:
1. A receded near point of convergence (NPC) (6 cm or greater)
(Hayes 1998; Scheiman 2003);
2. Insu'icient PFV at near (i.e. less than twice the near phoria
(Sheard's criterion) or PFV less than 15 ∆) (Sheard 1930;
Scheiman 2002b).
We analyzed data for children (< 18 years old) and adults (18 years
or older) separately because the e'ectiveness of the interventions
are likely to be di'erent in these two populations. The transitivity
assumption for NMA is more likely to hold by analyzing these two
populations separately.
Types of interventions
We included trials comparing any form of non-surgical intervention
against placebo, no intervention, a sham intervention, or another
type of intervention, for patients with convergence insu'iciency.
Based on our knowledge and a preliminary review
of literature, possible nodes for NMA included home-
based convergence exercises (pencil/target push-ups), home-
based computer vergence/accommodative therapy, o'ice-based
vergence/accommodative therapy, base-in prism reading glasses,
base-in prism glasses combined with progressive addition lenses,
and placebo or sham intervention. All these interventions
are available for patients and can be used for convergence
insu'iciency. Therefore, the concept of "joint randomizability"
applies to all interventions included in the network (Salanti 2012).
Note that some of the interventions might not be connected to the
main network for analysis.
Types of outcome measures
Primary outcomes
We introduced 'treatment success at 12 weeks' as a new outcome,
during this review's current update. Treatment success is defined
in two ways:
1. Composite convergence outcome: achieved normal and
improved NPC and PFV: NPC is normal (< 6 cm) and has improved
by ≥ 4 cm; PFV is normal (passing Sheard's criterion and a PFV
break > 15 ∆) and has improved ≥ 10 ∆; and
2. Composite signs (convergence) and symptoms outcome:
achieved normal and improved NPC, PFV, and Convergence
Insu'iciency Symptom Survey (CISS) score: NPC is normal (< 6
cm) and has improved by ≥ 4 cm, PFV is normal (passing Sheard's
criterion and a PFV break > 15 ∆) and has improved ≥ 10 ∆, and
CISS is normal (< 16) and has improved ≥ 10 points.
We introduced these two outcome measures to this review because
the treatment of convergence insu'iciency is designed to improve
patients’ convergence ability. Clinically, we evaluate this function
based on the two clinical convergence measurements that are
used to diagnose convergence insu'iciency: NPC and PFV. The
expectation is that both of these clinical measures should no
longer be deficient aHer successful treatment for convergence
insu'iciency with active forms of therapy. Because there are
no data to indicate that one convergence measure is more
important than the other, both measures were used in defining
this 'composite convergence outcome.' Evaluating whether a pre-
determined magnitude of improvement occurred for both clinical
measures was deemed to be a more robust indication of successful
treatment than using either clinical measure by itself. In addition,
we incorporated a second outcome measure (composite signs and
symptoms) that added patient-reported symptoms (using the CISS)
to the composite convergence outcome of NPC and PFV. These two
outcome measures have been reported previously (CITT 2008; CITT-
ART 2019).
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When the follow-up period was shorter than 12 weeks, we analyzed
outcome data at the longest follow-up point. When the follow-up
period was longer than 12 weeks, we analyzed outcome data at the
time point closest to 12 weeks.
Secondary outcomes
We considered NPC and PFV measures at near aHer 12 weeks
of intervention (the primary outcomes of earlier versions of this
review) to be secondary outcomes.
In addition, we analyzed participant symptoms at 12 weeks, as
reported in the included studies. We assessed symptoms whenever
trials had used some formal instrument for examining symptoms
(Borsting 2003; Rouse 2004; Rouse 2009). One instrument that
has been developed and validated for assessing convergence
insu'iciency symptoms before and aHer treatment is the CISS
Version 15, a 15-item questionnaire that measures symptoms
experienced when reading or doing other close work (Borsting
2003; Rouse 2004; Rouse 2009). The higher the CISS score, the more
symptoms experienced by the patient. In di'erentiating individuals
with symptomatic convergence insu'iciency from those with
normal binocular vision, the CISS was shown to have a sensitivity
of 96% and specificity of 88%, when using a cut-o' score of ≥ 16 for
children (Borsting 2003; Rouse 2009), and a sensitivity of 98% and
specificity of 87%, when using a cut-o' score ≥ 21 for adults (Rouse
2004).
We reported adherence to treatment.
Adverse outcomes
Adverse e'ects of interest included worsening of diplopia (double
vision), worsening of headaches, and convergence spasm.
We summarized the reported adverse e'ects related to each
intervention.
Quality of life data
We planned to describe data on quality of life when available from
included trials.
Search methods for identification of studies
Electronic searches
The Cochrane Eyes and Vision Information Specialist searched the
following electronic databases for randomized controlled trials and
controlled clinical trials. There were no restrictions to language or
year of publication. The electronic databases were last searched on
20 September 2019.
• Cochrane Central Register of Controlled Trials (CENTRAL; 2019,
Issue 9) (which contains the Cochrane Eyes and Vision Trials
Register) in the Cochrane Library (searched 20 September 2019)
(Appendix 1).
• MEDLINE Ovid (1946 to 20 September 2019) (Appendix 2).
• Embase.com (1947 to 20 September 2019) (Appendix 3).
• PubMed (1948 to 20 September 2019) (Appendix 4).
• metaRegister of Controlled Trials (mRCT) (www.controlled-
trials.com; last searched 6 October 2010 as this database is no
longer available) (Appendix 5)
• US National Institutes of Health Ongoing Trials
Register ClinicalTrials.gov (www.clinicaltrials.gov; searched 20
September 2019) (Appendix 6).
• World Health Organization (WHO) International Clinical Trials
Registry Platform (ICTRP) (www.who.int/ictrp; searched 20
September 2019) (Appendix 7).
Searching other resources
We searched the reference lists of identified trial reports to find
additional trials. We used the Science Citation Index (SCI) to
find studies that had cited the reports of included trials. We
contacted the primary investigators of identified trials for details of
additional trials when needed. We also conducted manual searches
of the following journals: Journal of the American Optometric
Association (1990 to 2009); Journal of Behavioral Optometry
(1990 to 2009); Optometry & Vision Development (1969 to 2009);
American Orthoptic Journal (1951 to 2009); Australian Orthoptic
Journal (1973 to 2009); and British and Irish Orthoptic Journal
(formerly the British Orthoptic Journal) (1954 to 2009).
Data collection and analysis
Selection of studies
At least two review authors independently reviewed the titles
and abstracts resulting from the electronic and manual searches
according to the eligibility criteria stated above. We classified
abstracts as 'definitely exclude,' 'unsure,' or 'definitely include.' We
obtained the full text for articles in the 'unsure' and 'definitely
include' categories and re-assessed them for final eligibility. AHer
examining the full text, studies labeled as 'excluded' by both
authors were not included in the review and the reasons for
exclusion documented. Included studies were assessed further for
their methodological quality. We resolved discrepancies through
discussion and consensus.
Data extraction and management
At least two review authors independently extracted the data
onto paper data collection forms. We resolved discrepancies
through discussion. One review author entered all data into Review
Manager 5 (RevMan 5) (Review Manager 2014). Data entered
were verified by a second author. We extracted the following
details from the studies, including those relevant for assessing
the transitivity assumption: methods, participants, interventions,
outcomes, adverse events, quality of life issues, economic data,
and important information not captured otherwise. We requested
and received individual participant data on treatment success from
PEDIG 2016.
Assessment of risk of bias in included studies
At least two review authors assessed the sources of potential
systematic bias in trials according to the first version of the
Cochrane risk of bias tool, described in Chapter 8 of the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2017).
The following parameters were considered: a) randomization
sequence generation; b) allocation concealment; c) masking
(blinding) of the primary and secondary outcome assessors; d)
completeness of outcome data for the primary and secondary
outcomes; and e) selective outcome reporting. Each of the
parameters was graded as being at 'low risk of bias,' 'high risk
of bias,' or 'unclear risk of bias.' Because of the nature of the
intervention, masking of participants and care providers was not
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possible in all trials, and consequently was not used as a quality
parameter in this review.
The version of 'Risk of bias' tool we used did not incorporate an
algorithm to derive an overall risk of bias for each trial. In order to
use the Confidence in Network Meta-Analysis (CINeMA) framework
developed by Salanti and colleagues for evaluating the confidence
in the evidence from the NMAs (Salanti 2014), we judged the overall
risk of bias of a trial as high if two more domains (out of a total of
six domains) were rated at 'high risk of bias,' unclear if four or more
domains were rated at 'unclear risk of bias,' and low if five or more
domains were rated at 'low risk of bias.'
Measures of treatment eect
We calculated a summary risk ratio (RR) for dichotomous outcomes
and mean di'erence (MD) between interventions for continuous
outcomes. We reported the estimate of e'ect and associated 95%
confidence intervals (CI).
Unit of analysis issues
We conducted a person-based analysis because convergence
insu'iciency is a binocular vision disorder. None of the trials
included in this review used a cluster or cross-over design. We
included all eligible treatment groups from multi-arm trials in the
NMA without combining any groups.
Dealing with missing data
We contacted the lead investigator of the trial in an attempt
to obtain additional information, when necessary. Whenever the
authors did not respond within four weeks, we continued the
review based on the available information.
Assessment of heterogeneity
We assessed clinical and methodological heterogeneity
qualitatively by examining the characteristics of each included trial.
We assessed statistical heterogeneity quantitatively using the Chi2
test and the I2 values. We pre-specified that a P value of less than 0.1
from the Chi2 test and an I2 statistic of greater than 50% indicated
substantial statistical heterogeneity.
Assessment of reporting biases
We planned to use a funnel plot to assess publication bias if a
su'icient number of trials were identified.
Data synthesis
We analyzed two networks of trials. One network comprised
the trials with children as participants and the other comprised
the trials with adult participants. For each network, we first
conducted a pairwise meta-analysis for every direct comparison
using a random-e'ects model. We then fitted random-e'ects NMA
models following the multivariate approach by Chaimani and White
(Chaimani 2013; Chaimani 2015; White 2015). We executed these
analyses using Stata packages ‘mvmeta,' ‘network,' and ‘network
graphs,’ assuming a common heterogeneity across all comparisons
in the network. We generated the e'ect estimates (RR or MD)
between any two interventions in the network and used the 'mean
rank' value to rank the interventions on all outcomes where NMA
was possible. For the children's network, we excluded Nehad 2018
due to data errors discovered in the manuscript. Authors of Nehad
2018 did not respond to our inquiry for clarification.
The indirect comparisons made in the NMA are built on the
assumptions of transitivity and coherence (Salanti 2012). The
transitivity assumption indicates that the indirect comparison is
a valid estimation of the unobserved direction comparison, the
validity of which can be conceptually evaluated. The transitivity
assumption is likely to hold in our data because the interventions
analyzed are all treatments for convergence insu'iciency. The
coherence assumption implies agreement between direct and
indirect estimates, which can be tested statistically. We evaluated
the coherence assumption using the loop-specific approach
(Bucher 1997; Veroniki 2013). When statistical incoherence was
detected, we first examined the trial characteristics, and then
conducted a sensitivity analysis by fitting an incoherence model.
We used STATA 14 (StataCorp LP, College Station, TX) for all
analyses. Raw data for all analyses are available on request.
Subgroup analysis and investigation of heterogeneity
We examined potential sources of heterogeneity qualitatively. As
described above, to control for known heterogeneity, we analyzed
the children's and adults' networks separately.
Sensitivity analysis
We pre-specified that we would conduct sensitivity analyses to
determine the impact of exclusion of studies at higher risk of
bias, unpublished studies, and industry-funded studies. However,
because there were so few studies for the NMA, we did not conduct
any sensitivity analyses. The incoherence model for NMA did not
converge.
Evaluating confidence in the evidence
We used the CINeMA framework by Salanti and colleagues
for evaluating the confidence in the evidence from the NMAs
(Salanti 2014) for treatment success (using both definitions). This
approach covers six confidence domains: within-study bias (i.e.,
risk of bias in the included studies), across-studies bias (i.e.,
publication and other reporting bias in the included studies),
indirectness, imprecision, heterogeneity, and incoherence. CINeMA
assigns judgements at three levels (no concerns, some concerns,
or major concerns) to each of the six domains. Judgements across
the six domains are then summarized to obtain four levels of
confidence for each relative treatment e'ect, corresponding to
the usual GRADE approach: very low, low, moderate, or high
(Nikolakopoulou 2019). Among the six confidence domains, the
domains for within-study bias and indirectness are based on the
contribution made by each study to each estimate of e'ect on a 0 to
100 percent scale ("percentage contribution matrix"). Judgement
on imprecision, heterogeneity, and incoherence relies on defining
relative treatment e'ects that exclude any clinically important
di'erences in outcomes between interventions. For treatment
success expressed in RR, we used a margin of equivalence of (0.8
to 1.25) for this purpose. This interval is symmetrical on the natural
logarithm scale.
R E S U L T S
Description of studies
Results of the search
The electronic searches identified 1526 unique records (Figure
1). We screened the records and obtained full-text reports of 72
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records. AHer assessment we included 16 records reporting on
12 trials that were relevant to this systematic review (Aletaha
2018; Birnbaum 1999; CITT 2005a; CITT 2005b; CITT 2005c; CITT
2008; CITT-ART 2019; PEDIG 2016; Momeni Moghaddam 2015;
Nabovati 2020; Nehad 2018; Widmer 2018). We excluded 60 studies,
see Characteristics of excluded studies for details. A study by
Teitelbaum 2009 was included in the previous version of this
review, however it has been re-assessed and is now an excluded
study as the participants did not meet the clinical definition of
convergence insu'iciency. The following four studies are classed
as ongoing trials and will be assessed when data becomes
available (CTRI/2018/05/013560; DRKS00014187; NCT03593031;
U1111-1194-7855).
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Figure 1.   Study flow diagram
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Included studies
We have presented the characteristics for each included study in the
'Characteristics of included studies' table.
We included 12 trials with a total of 1289 participants with
convergence insu'iciency. We excluded Nehad 2018 from analysis
due to data errors discovered in the manuscript. We contacted
the authors and asked them to clarify the data discrepancies,
but they failed to respond. Eight trials were conducted in the
United States, three in Iran, and one in Egypt. The trials varied
in size, with the smallest enrolling seven participants (Widmer
2018) and the largest enrolling 311 participants (CITT-ART 2019;
one participant was determined ineligible aHer randomization).
Five of the included trials, funded by the National Eye Institute
of the US National Institutes of Health, were conducted by the
CITT Study Group (CITT 2005a; CITT 2005b; CITT 2005c; CITT 2008;
CITT-ART 2019). These trials randomized 697 (54%) of participants
included in this systematic review. Symptomatic convergence
insu'iciency was defined consistently across the five CITT trials
and the eligibility criteria were also comparable. Six other trials
(Aletaha 2018; PEDIG 2016; Momeni Moghaddam 2015; Nabovati
2020; Nehad 2018; Widmer 2018) adopted similar eligibility criteria
to the CITT trials. The remaining trial (Birnbaum 1999) enrolled 60
adult male participants from a US Veterans Health Administration
Medical Center.
We found clinical heterogeneity in several aspects, mainly in the
age distribution of trial participants. Six trials were conducted
in participants < 18 years of age (CITT 2005a; CITT 2005b; CITT
2008; CITT-ART 2019; PEDIG 2016; Nehad 2018); five trials were
conducted in young adult participants up to 40 years of age
(Aletaha 2018; CITT 2005c; Momeni Moghaddam 2015; Nabovati
2020; Widmer 2018); the remaining trial was conducted in adults 40
years or older (Birnbaum 1999). Because of age-related di'erences
in accommodation, it was important to analyze the findings for
children separately from young adults and from presbyopic adults.
Types of interventions
The included trials evaluated a variety of interventions, including
passive treatment with base-in prism reading glasses, and active
treatments with o'ice-based vergence/accommodative therapy,
basic home-based convergence therapy (pencil/target push-
ups), home-based computer vergence/accommodative therapy
plus pencil push-ups, and placebo or sham procedures. The
interventions and comparison interventions are described in detail
in the 'Characteristics of included studies' table and Table 1. We
kept the same terms that were used in the trials to refer to each
intervention.
Aletaha 2018 randomly assigned 84 participants (aged 15 to 35
years) to 6 weeks of home-based pencil push-ups, o'ice-based
vision therapy (major amblyoscope only) with home-based pencil
push-ups, or augmented o'ice-based vision therapy using both
the major amblyoscope and also convergence procedures (-3.00D
lenses and base-out prism while performing near tasks) with
additional home-based reinforcement. The outcome visit was 12
weeks aHer the completion of treatment.
Birnbaum 1999 randomly assigned 60 male adults (≥ 40
years; median age 65 years) to receive o'ice-based vergence/
accommodative therapy with supplemental home therapy, home-
based convergence therapy only, or no treatment (control) for 24
weeks with the primary outcome visit aHer 24 weeks.
CITT 2005a randomly assigned 72 children nine to 18 years
of age with symptomatic convergence insu'iciency to wear
either base-in prism reading glasses or placebo reading glasses.
Participants assigned to base-in prism reading glasses received
glasses that corrected the participants' refractive error, when
necessary, and base-in prism. Participants in the placebo reading
glasses group received glasses that corrected their refractive error
when necessary, or plano lenses for those who did not require
refractive correction. Participants were asked to wear these glasses
for all reading and near tasks requiring more than five minutes for
the six-week study duration.
CITT 2005b was considered as a pilot study by the CITT Study
Group. In this study, 47 children were randomly assigned to
receive a 12-week program of home-based pencil push-ups, o'ice-
based vergence/accommodative therapy, or o'ice-based placebo
therapy, with the primary outcome visit aHer 12 weeks. These same
three treatment modalities were also evaluated in 46 young adults
(ages 19 to 30 years) in CITT 2005c.
CITT 2008 randomly assigned 221 children to receive a 12-
week program of home-based pencil push-ups, home-based
computer vergence/accommodative therapy plus pencil push-
ups, o'ice-based vergence/accommodative therapy with home
reinforcement, or o'ice-based placebo therapy, with the primary
outcome visit aHer 12 weeks. The home-based computer
vergence/accommodative therapy plus pencil push-ups group was
considered a more intensive regimen than pencil push-ups alone.
The other three treatment modalities were essentially the same as
those in the aforementioned CITT trials.
CITT-ART 2019 randomly assigned 311 children nine to 14 years of
age to receive a 16-week program of weekly o'ice-based vergence/
accommodative therapy or o'ice-based placebo therapy, with the
primary outcome visit aHer 16 weeks.
PEDIG 2016 randomized 204 children nine to 18 years of age
to receive 12 weeks of either home-based computer vergence/
accommodative therapy, home-based pencil push-ups, or home-
based placebo intervention, with the primary outcome visit aHer 12
weeks.
Momeni Moghaddam 2015 randomly assigned 60 young adults
(mean age 21.3 ± 0.9 years) to 8 weeks of home-based pencil push-
ups or o'ice-based vergence/accommodative therapy, with the
primary outcome visit aHer 8 weeks.
Nabovati 2020 randomly assigned 64 young adults 18 to 40 years of
age to wear either base-in prism reading glasses or placebo reading
glasses for all near work activities lasting more than 15 minutes for
12 weeks, with the primary outcome visit aHer 12 weeks.
Nehad 2018 randomized 113 children seven to 13 years of age to
receive 12 weeks of o'ice-based vergence/accommodative therapy
or o'ice-based vergence/accommodative therapy with additional
home-based computer vergence/accommodative therapy, with the
primary outcome visit aHer 12 weeks.
Widmer 2018 undertook an fMRI study to investigate changes
in brain activation in response to o'ice-based vergence/
accommodative therapy. Seven adult participants (18 to 30 years
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of age) with convergence insu'iciency were randomized to receive
either 12 weeks of o'ice-based vergence/accommodative therapy
(n = 4) or placebo therapy (n = 3), with the primary outcome visit
aHer 12 weeks.
Types of outcomes
Eleven of the 12 included trials used consistent outcome measures.
The primary outcome for Aletaha 2018, Nabovati 2020, and four
of the CITT trials (CITT 2005a; CITT 2005b; CITT 2005c; CITT 2008)
was symptom improvement as measured by the CISS V-15 (Borsting
2003; Rouse 2009;). Aletaha 2018 measured the CISS one week aHer
the six-week therapy program concluded (primary outcome visit)
and subsequently 12 weeks and 24 weeks aHer discontinuation
of therapy. The CISS was evaluated aHer six weeks in CITT 2005a,
and measured aHer 12 weeks of therapy in the following trials:
CITT 2005b; CITT 2005c; CITT 2008; Widmer 2018. Secondary
outcome measures of NPC and PFV at near were available in all
of these studies. The secondary outcomes for CITT-ART 2019 were
NPC and PFV, evaluated aHer 16 weeks of therapy. The primary
and secondary outcome measures were not explicitly specified in
Birnbaum 1999, but the study examined "success" and "failure,"
defined by the investigators on the basis of the improvement shown
with respect to the asthenopia and functional criteria. The primary
outcome for PEDIG 2016, Momeni Moghaddam 2015, and Nehad
2018 was a combination of CISS score, NPC, and PFV, measured
aHer either eight weeks (Momeni Moghaddam 2015) or 12 weeks
(PEDIG 2016; Nehad 2018) of therapy.
Excluded studies
We excluded 60 reports that initially appeared to be relevant (see
reasons in the 'Characteristics of excluded studies' table).
Risk of bias in included studies
We evaluated the risk of bias in each of the 12 included trials, using
eight pre-specified criteria. Three trials (Aletaha 2018; PEDIG 2016;
Nabovati 2020) were judged to have high potential for bias in two
domains. Ten trials were judged to have unclear risk of bias in two
or more domains (Figure 2).
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Aletaha 2018 + ? - - ? ? ?
Birnbaum 1999 ? ? ? ? + + ?
CITT 2005a + + + + ? ? +
CITT 2005b + + + + ? ? +
CITT 2005c + + + + ? ? +
CITT 2008 + + + + ? ? +
CITT-ART 2019 + + + + + + +
Momeni Moghaddam 2015 + ? ? ? + + ?
Nabovati 2020 + ? - - + + ?
Nehad 2018 ? ? ? ? ? ? ?
PEDIG 2016 + + + + - - +
Widmer 2018 ? + + + + + ?
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Allocation
Birnbaum 1999 and Nehad 2018 did not report the procedure
used to generate random sequences and whether the intervention
allocation was concealed until assigned. Aletaha 2018, Momeni
Moghaddam 2015 and Nabovati 2020 did not report whether
the intervention allocation was concealed until assigned.
When participant assignment involves a non-random approach,
confounding and selection bias may be introduced. Five RCTs
(CITT 2005a; CITT 2005b; CITT 2005c; CITT 2008; CITT-ART 2019)
used a central study website to randomize study participants, and
the treatment assignment was concealed to researchers enrolling
and allocating participants. PEDIG 2016 and Widmer 2018 also
adequately concealed the allocation (personal communication
with the review authors).
Blinding
Aletaha 2018 and Nabovati 2020 were judged to have high potential
risk of bias because the outcome assessors were not blinded
(masked to participant treatment assignment). Birnbaum 1999,
Momeni Moghaddam 2015, and Nehad 2018 did not report whether
the primary or the secondary outcomes were measured by masked
personnel. Inadequate masking may introduce information bias.
The other seven trials (CITT 2005a; CITT 2005b; CITT 2005c; CITT
2008; CITT-ART 2019; PEDIG 2016; and Widmer 2018) reported that
masking was used for the primary and secondary outcomes.
Incomplete outcome data
PEDIG 2016 was judged to have a high potential risk of attrition bias
arising from di'erential loss to follow up among treatment groups
with missing outcome visits for 8%, 19%, and 30% of participants
in the home-based computer vergence, home-based near target
push-up, and home-based placebo groups, respectively. Aletaha
2018 and Nehad 2018 did not report whether the outcome data
were complete. Personal communication of the review authors
with the CITT trial statistician revealed that missing data were
not imputed in the four CITT trials (CITT 2005a; CITT 2005b; CITT
2005c; CITT 2008).Therefore, available outcome data were used in
the analyses. For CITT 2008, 218/221 (99%) completed the outcome
visit. In CITT-ART 2019, data were complete for 97% of the 206
participants in the vergence/accommodative group and 100% of
the 104 participants in the placebo group. No participants were
lost to follow-up in Birnbaum 1999. Follow-up was high in Nabovati
2020 (97% in the prism group and 93% in the placebo group).
Selective reporting
We had insu'icient information to assess the risk of selective
reporting bias in Aletaha 2018, Birnbaum 1999, Momeni
Moghaddam 2015; Nabovati 2020; Nehad 2018; and Widmer 2018.
All outcomes described in the study protocol or trial registration of
the remaining six trials (CITT 2005a; CITT 2005b; CITT 2005c; CITT
2008; CITT-ART 2019; PEDIG 2016c) were reported.
Eects of interventions
Children's network
The included trials for children assessed seven interventions,
numbered as follows:
1. o'ice-based vergence/accommodative therapy with home
reinforcement;
2. home-based pencil/target push-ups;
3. home-based computer vergence/accommodative therapy;
4. o'ice-based vergence/accommodative therapy alone;
5. placebo vergence/accommodative therapy or other placebo
intervention;
6. prism reading glasses; and
7. placebo reading glasses.
Interventions 1, 2, 3 and 5 formed a network, in which interventions
were connected by RCTs comparing at least two of them (Figure 3).
Interventions 6 and 7 were disconnected from the network because
they were only compared with each other in CITT 2005a but not with
other interventions. Interventions 1 and 4 were assessed in Nehad
2018, but we excluded this trial from analysis due to data errors.
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Figure 3.   Network graph for the children's network Number of trials: 4 Number of participants analyzed: 737
 
Table 2 shows the pairwise meta-analysis results based on the
direct comparisons of two interventions from RCTs, including
interventions 6 and 7. There was no evidence of a di'erence
between prism reading glasses and placebo reading glasses for the
outcomes of NPC, PFV, or CISS score.
Table 3 shows the relative e'ects of interventions 1, 2, 3, and 5 and
the mean ranks based on NMAs of four RCTs (737 participants).
Treatment success (composite convergence outcome)
Compared with placebo intervention, RR estimates for treatment
success, using the composite convergence outcome (defined as
achieving a normal and pre-specified improvement in both NPC
and PFV), ordered from the most e'ective to the least e'ective
therapy, based on the mean ranks, were as follows: o'ice-
based vergence/accommodative therapy with home reinforcement
(RR 3.04, 95% CI 2.32 to 3.98; high-certainty evidence); home-
based computer vergence/accommodative therapy (RR 1.55, 95%
CI 1.00 to 2.41; moderate-certainty evidence); and home-based
pencil/target push-ups (RR 1.08, 95% CI 0.66 to 1.74; low-
certainty evidence). We found high-certainty evidence that o'ice-
based vergence/accommodative therapy with home reinforcement
increases the chance of a successful outcome compared with:
home-based computer vergence/accommodative therapy (RR1.96,
95% CI 1.32 to 2.94); home-based pencil/target push-ups (RR 2.86,
95% CI: 1.82 to 4.35); and placebo (RR 3.04, 95% CI: 2.32 to 3.98).
There was no evidence of di'erences between the two home-based
therapies or between the two home-based therapies and placebo
intervention for this outcome (Table 3). The certainty of evidence
and any reasons for downgrading for each pair-wise comparison are
available in Table 3 and Figure 4.
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Figure 4.   Composite convergence outcome: achieved normal and improved NPC and PFV: NPC is normal (<6cm)
and has improved by ≥4cm; PFV is normal (passing Sheard's criterion and a PFV break > 15 ∆) and has improved ≥
10 ∆. The certainty of evidence was rated 'high' if all domains were of 'no concerns.' The certainty of evidence was
rated 'moderate' if two or more domains were of 'some concerns.' The certainty of evidence was rated 'low' if two or
more domains were of 'major concerns' or one domain of 'major concerns' plus one domain of 'some concerns.' CI:
confidence interval.
 
Treatment success (composite convergence/symptoms outcome)
Compared with placebo intervention, RR estimates for treatment
success, using the composite convergence signs and symptoms
outcome (defined as achieving normal and improved NPC, PFV,
and CISS), ordered from the most e'ective to the least e'ective
therapy, based on the mean ranks, were as follows: o'ice-based
vergence/accommodative therapy with home reinforcement (RR
5.12, 95% CI 2.01 to 13.07; moderate-certainty evidence); home-
based pencil/target push-ups (RR 1.16, 95% CI 0.31 to 4.35;
low-certainty evidence); and home-based computer vergence/
accommodative therapy (RR 1.10, 95% CI 0.28 to 4.40; low-certainty
evidence). O'ice-based vergence/accommodative therapy with
home reinforcement was more e'ective than the two home-
based therapies and placebo intervention. However, there was no
evidence of di'erence between the two home-based therapies or
between the two home-based therapies and placebo intervention
for this outcome (Table 3). The certainty of evidence and any
reasons for downgrading for each pair-wise comparison are shown
in Table 3 and Figure 5.
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Figure 5.   Composite signs (convergence) and symptoms outcome: achieved normal and improved NPC, PFV, and
Convergence Insuiciency Symptom Score (CISS): NPC is normal (<6cm) and has improved by ≥ 4cm, PFV is normal
(passing Sheard's criterion and a PFV break > 15∆) and has improved ≥ 10 ∆, and CISS is normal (< 16) and has
improved ≥ 10 points. The certainty of evidence was rated 'high' if all domains were of 'no concerns.' The certainty of
evidence was rated 'moderate' if two or more domains were of 'some concerns.' The certainty of evidence was rated
'low' if two or more domains were of 'major concerns' or one domain of 'major concerns' plus one domain of 'some
concerns.' CI: confidence interval.
 
Near point of convergence
Compared with placebo intervention, the mean improvements
(reduction) in NPC, ordered from the most e'ective to the least
e'ective therapy, based on the mean ranks, were as follows: o'ice-
based vergence/accommodative therapy with home reinforcement
(MD 5.01, 95% CI 3.56 to 6.46); home-based computer vergence/
accommodative therapy (MD 2.93, 95% CI 1.03 to 4.83); and home-
based pencil/target push-ups (MD 1.58, 95% CI -0.33 to 3.49) (Table
3).
Positive fusional vergence at near
Compared with placebo intervention, the mean improvements
(increase) in PFV, ordered from the most e'ective to the least
e'ective therapy, based on the mean ranks, were as follows: o'ice-
based vergence/accommodative therapy with home reinforcement
(MD 13.78, 95% CI 11.41 to 16.14); home-based computer vergence/
accommodative therapy (MD 5.26, 95% CI 2.72 to 7.81); and home-
based pencil/target push-ups (MD 0.68, 95% CI -1.67 to 3.04) (Table
3).
Convergence insuiciency symptom survey
Compared with placebo intervention, the mean improvements
(reduction) in CISS score, ordered from the most e'ective to
the least e'ective therapy, based on the mean ranks, were as
follows: o'ice-based vergence/accommodative therapy with home
reinforcement (MD 6.79, 95% CI 1.21 to 12.36); home-based
computer vergence/accommodative therapy (MD -1.84, 95% CI
-7.95 to 4.27); and home-based pencil/target push-ups (MD -3.13,
95% CI -8.65 to 2.38) (Table 3).
Adverse eects
No adverse e'ects related to study treatments were reported for
any of the included studies.
Assessment of the transitivity assumption
We found no evidence of statistically significant incoherence for
overall treatment success (defined by either of the composite
success criteria). However, we found evidence of statistically
significant incoherence for the CISS score in two triangle loops. One
included interventions 1, 2, and 3, with an incoherence factor of
10.25 (95% CI 1.23 to 19.27), and the other included interventions
1, 3, and 5, with an incoherence factor of 5.47 (95% CI 0.21 to 10.74).
Because all trials measured CISS scores using the same instrument
and in a consistent way, and because there was no statistically
significant incoherence for the other two outcomes, we did not have
a good qualitative explanation for the statistical incoherence. We
tried to fit an incoherence model, but the model failed to converge
due to the limited numbers of trials analyzed.
Adults' network
The eligible trials on adults examined interventions 1, 2, 4, and
5, of the seven interventions enumerated above. These four
interventions constructed a network (Figure 6).
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Figure 6.   Network graph for the adults' network Number of trials: 3 Number of participants analyzed: 107
 
Table 4 shows the pairwise meta-analysis results based on the
direct comparison of two interventions from RCTs. Table 5 shows
the relative e'ects of any two interventions and the mean ranks
based on NMAs of three RCTs (107 participants).
Treatment success (composite convergence outcome)
No trials presented data on this outcome.
Treatment success (composite convergence/symptoms outcome)
No trials presented data on this outcome.
Near point of convergence
Compared with placebo therapy, the mean improvement
(reduction) in NPC, ordered from the most e'ective to the least
e'ective therapy, based on the mean ranks, were as follows: o'ice-
based vergence/accommodative therapy alone (MD 3.33, 95% CI
-0.49 to 7.15); o'ice-based vergence/accommodative therapy with
home reinforcement (MD 2.43, 95% CI -0.02 to 4.87); and home-
based pencil/target push-ups (MD -0.29, 95% CI -5.56 to 4.98).
Positive fusional vergence at near
Compared with placebo therapy, the mean improvement (increase)
in PFV, ordered from the most e'ective to the least e'ective
therapy, based on the mean ranks, were as follows: o'ice-based
vergence/accommodative therapy with home reinforcement (MD
16.73, 95% CI 6.96 to 26.50); o'ice-based vergence/accommodative
therapy alone (MD 12.92, 95% CI -1.75 to 27.60); and home-based
pencil/target push-ups (MD 6.40, 95% CI -6.46 to 19.25).
Convergence insuiciency symptom survey
Compared with placebo therapy, the mean improvement
(reduction) in CISS score, ordered from the most e'ective to
the least e'ective therapy, based on the mean ranks, were as
follows: o'ice-based vergence/accommodative therapy alone (MD
3.23, 95% CI -6.61 to 13.07); o'ice-based vergence/accommodative
therapy with home reinforcement (MD 3.03, 95% CI -6.33 to 12.39);
and home-based pencil/target push-ups (MD -1.46, 95% CI -10.77 to
7.85).
One trial (Nabovati 2020), disconnected from the network,
evaluated base-in prism glasses prescribed for near-work activities
and found evidence that the base-in prism glasses group had
less symptoms compared with the placebo glasses group at three
months (MD -8.9, 95% CI-11.6 to -6.3); no evidence of di'erence was
found in NPC or PFV.
Adverse eects
No adverse e'ects related to study treatments were reported for
any of the included studies.
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Assessment of the transitivity assumption
We found no evidence of statistically significant incoherence for any
of the outcomes in the adult network.
Adherence with treatment
Treatment adherence is the degree to which study participants
comply with the prescribed treatment regimen. The proportion of
o'ice therapy visits completed is the typical measure of treatment
adherence for o'ice-based therapy. Determining participant
adherence with a home treatment or the home-based component
of an o'ice-based therapy regimen, however, is more challenging
because these estimates are typically based, at least in part,
on participant or parental report. Several studies have provided
estimates of treatment adherence.
In the CITT trial of base-in prism for children (CITT 2005a),
adherence was assessed by asking the child and parent to report
the frequency (0%, 25%, 50%, 75%, or 100%) with which the child
wore the study glasses for reading or near work. In the base-in
prism group, 90% of the children and 81% of their parents reported
that the glasses were worn at least 75% of the prescribed time.
For the placebo group, 79% of the children and 79% of the parents
reported that the frequency of glasses wear was 75%. The reported
percentage of glasses wearing time for the adult participants in the
Nabovati study of base-in prism was 83% and 79% for the prism and
placebo groups, respectively (Nabovati 2020).
Adherence data for therapy performed in the o'ice can be deduced
from the proportion of therapy visits completed compared with
visits scheduled. Two of the CITT trials reported these data (CITT
2008; CITT-ART 2019).
In CITT 2008, adherence with the 12 weekly therapy visits was
excellent at 97.6% for the o'ice-based vergence/accommodative
therapy group and 97.2% for the placebo therapy group. There
was also excellent adherence for the o'ice-based therapies in CITT-
ART 2019, with 96.8% and 96.6% of therapy visits completed for
the 16 sequential weeks of o'ice-based vergence/accommodative
therapy and placebo therapy, respectively.
The CITT trials (CITT 2005b; CITT 2005c; CITT 2008; CITT-ART
2019) of o'ice-based vergence/accommodative therapy with a
prescribed home therapy component, and the PEDIG CITS trial
(PEDIG 2016) of solely home therapy procedures, determined
treatment adherence based on therapist opinion, gathered from
participant and/or parent interview, or some combination of
interview, calendar log, and/or electronic data from those
prescribed computer therapy procedures (Table 6). In the four
CITT trials in which o'ice-based vergence/accommodative therapy
supplemented with home therapy procedures were evaluated
(CITT 2005b; CITT 2005c; CITT 2008; CITT-ART 2019), the therapist
estimated the average proportion of time (0%, 1% to 24%, 25% to
49%, 50% to 74%, 75% to 99%, or 100%) the participant adhered
to the home therapy protocol (Table 6). For the most recent trials
(CITT 2008; CITT-ART 2019; PEDIG 2016), study personnel also used
electronic data based on computer therapy usage (when computer
therapy was a component of the prescribed home therapy) for
their estimates of treatment adherence. A substantial decrease
in therapy adherence was reported for week 7 through week 12,
versus week 1 through week 6, for participants in the CITS home
therapy study, particularly in the home-based pencil push-up and
home-based placebo groups, who were also less likely to complete
the study than those in the home-based computer group (PEDIG
2016).
Economic data
Cost-analysis data (i.e. separate calculations of monetary and
health outcomes and the relative value of the treatment modality
measured as the added cost to achieve an incremental health
benefit) are not available for any of the included studies.
However, the general out-of-pocket monetary costs for the di'erent
treatments can be described. The monetary cost of o'ice-
based vergence/accommodative therapy is dependent on the
therapy-visit fee and the number of therapy sessions completed.
However, because this therapy is a covered service by certain
medical insurance companies in the US and some publicly-funded
healthcare systems outside the US, the direct patient cost may
be reduced significantly or may be zero in these instances. The
cost of home-based therapy is out-of-pocket and determined by
the number of follow-up visits with the provider and the therapy
equipment that would need to be purchased to use at home, with
soHware for computer therapy typically having the highest cost.
Prism glasses would be covered by vision insurance in the US for
individuals having vision insurance, with additional o'ice-visit fees
for associated follow-up visits with the provider. In publicly-funded
healthcare systems, such as the National Health Service in the
United Kingdom, assistance for the cost of glasses for children and
other eligible groups is also available.
D I S C U S S I O N
Summary of main results
The objective of this systematic review was to identify and
synthesize the available RCT evidence on the e'ectiveness of non-
surgical treatments for symptomatic convergence insu'iciency in
children and adults. Seven RCTs that were not available at the time
of the last review are included in this updated version.
Summary of main results in children
There were a total of 968 participants in the six RCTs in the pediatric
population. The diagnostic criteria for convergence insu'iciency
and outcome measures were identical in four trials (CITT 2005a;
CITT 2005b; CITT 2008; CITT-ART 2019) and similar in two trials
(Nehad 2018; PEDIG 2016). The treatments evaluated were base-
in prism reading glasses and several o'ice- and home-based
vergence/accommodative therapy modes of therapy. The CITT
Investigator Group completed four of the six RCTs with 651
participants; all four RCTs were rated at low risk of bias (CITT 2005a;
CITT 2005b; CITT 2008; CITT-ART 2019).
We found high-certainty evidence that o'ice-based vergence/
accommodative therapy with home reinforcement was 3.04 times
more e'ective than placebo therapy, 2.86 times more e'ective
than home based pencil push-ups, and 1.96 times more e'ective
than home-based computer vergence/accommodative therapy in
achieving treatment success defined by normal and improved
clinical measures of convergence. However, there was no evidence
of any treatment di'erence between home-based pencil push-
ups and home-based computer vergence/accommodative therapy,
or between either of the two home-based therapies and placebo
therapy for treatment success.
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We found moderate-certainty evidence that participants who
received o'ice-based vergence/accommodative therapy with
home reinforcement were 5.12 times more likely to achieve
treatment success defined by normal and improved clinical
measures of convergence and symptoms than those who received
placebo therapy. We found low-certainty evidence that participants
who received o'ice-based vergence/accommodative therapy with
home reinforcement were 4.41 times more likely than those
received home based pencil push-ups, and 4.65 times more
likely than those who received home-based computer vergence/
accommodative therapy to achieve treatment success. Similar
to the aforementioned findings for treatment success using the
clinical measures of convergence, there was no evidence of
any treatment di'erence between home-based pencil push-ups
and home-based computer vergence/accommodative therapy, or
between either of the two home-based therapies and placebo
therapy for this measure of treatment success using symptoms and
clinical measures of convergence.
We also analyzed the e'ectiveness of the interventions for
improving the individual clinical measures of the NPC and PFV,
as well as symptoms measured by the CISS score. Compared
with placebo therapy, there was a statistically significant MD
favoring o'ice-based vergence/accommodative therapy with home
reinforcement for improving NPC, PFV, and the CISS score.
Compared with placebo, there was also a statistically significant MD
favoring home-based computer vergence/accommodative therapy
for improving NPC and PFV. However, for patient symptoms, there
was no statistically significant di'erence. Home-based pencil push-
up therapy yielded similar results to placebo therapy for all three
outcomes (i.e. NPC, PFV, and CISS score). This is an important
finding given the frequency in which home-based pencil push-
up therapy is prescribed as the sole treatment for children with
symptomatic convergence insu'iciency.
One RCT (CITT 2005a) evaluated the e'ectiveness of base-in
prism reading glasses for children with symptomatic convergence
insu'iciency (this comparison is disconnected from the network
analyzed). In this RCT, there was no statistically significant
di'erence in symptom improvement as measured by CISS scores
or in improvements in the clinical measures of NPC or PFV when
the base-in prism reading glasses group was compared with the
placebo reading glasses group.
Summary of main results in adults
We identified six RCTs using non-surgical interventions for treating
convergence insu'iciency in adults with a modest total number
of participants (n = 321). Only one RCT (CITT 2005c) was rated at
low risk of bias. Four RCTs (Birnbaum 1999; Momeni Moghaddam
2015; Aletaha 2018; Nabovati 2020) were graded as having a high
risk of bias and the remaining study (Widmer 2018) had only
seven participants. Participants were young adults in five of the
six clinical trials (CITT 2005c; Momeni Moghaddam 2015; Aletaha
2018; Widmer 2018; Nabovati 2020) whereas the mean age was 63.9
years in the remaining trial (Birnbaum 1999). Another problem is
the heterogeneity of the interventions. The treatment protocol for
the o'ice-based therapy interventions varied considerably (CITT
2005c; Momeni Moghaddam 2015; Aletaha 2018; Widmer 2018).
Only one study (Nabovati 2020) evaluated the e'ectiveness of base-
in prism reading glasses. In addition, most of the studies did not
include our primary outcome measures using composite success
data, which prevented us from conducting an NMA for the primary
outcome of treatment success (i.e. meeting the criteria for the
composite convergence outcome or for composite clinical signs
and symptoms outcome). We were thus limited to comparing mean
di'erences between the interventions for improvements in the
NPC, PFV, and symptoms individually.
Compared with placebo treatment, o'ice-based vergence/
accommodative therapy was relatively more e'ective in improving
PFV; the di'erences were not statistically significantly for the NPC
or the CISS score. There was no evidence of di'erences for any other
comparisons for any outcomes.
One trial (Nabovati 2020) evaluated base-in prism glasses
prescribed for near-work activities and found that the prism glasses
group had significantly less symptoms compared with the placebo
glasses group at three months; no evidence of di'erence was found
in NPC or PFV.
For both populations, no adverse e'ects related to study
treatments were reported for any of the included studies. Excellent
adherence was reported for o'ice-based vergence/accommodative
therapy (96.6% or higher) in three trials; reported adherence with
home-based therapy was less consistent with one study reporting
decreasing adherence (weeks 7 to 12) and lower completion rates
with home-based pencil/target push-ups.
Overall completeness and applicability of evidence
The population of interest were children and adults with
symptomatic convergence insu'iciency. Due to the di'erences in
the accommodative ability between children and adults, these
groups were analyzed separately. The included trials evaluated
the most commonly prescribed non-surgical interventions for
convergence insu'iciency. The majority or them used the same or
similar diagnostic criteria, based on specified thresholds for NPC,
PFV, and the CISS score.
For this 2020 update, we introduced 'treatment success at
12 weeks' as a new primary outcome, which was based on
achieving normal values together with pre-specified improvement
for NPC and for PFV (composite convergence outcome) and for
NPC, PFV and the CISS score (composite signs and symptoms
outcome). These data were available for trials included in the
children’s network. This composite outcome further enhances the
applicability of the evidence, as treatment success is likely to be the
most important outcome for patients and clinicians.
All of the included trials evaluated short-term outcomes (measured
at 16 weeks or less). In the case of studies with placebo
comparisons, this was due to the ethical and logistical challenges
of following a group of symptomatic patients in a placebo group.
It is therefore unclear whether the maximum treatment e'ect
that could have been achieved with the various interventions had
been reached. One study (CITT 2008) followed all asymptomatic
study participants for one year aHer the 12-week primary outcome
visit, reporting the percentage of participants that remained
asymptomatic in each group: 84% (27/32) for o'ice-based
vergence/accommodative therapy with home reinforcement, 67%
(10/15) for home-based pencil/target push-ups, 80% (8/10) for
home-based computer vergence/accommodative therapy, and
77% (10/13) for placebo therapy.
In terms of the magnitude of the treatment e'ect and the relative
ranking of interventions, o'ice based vergence/accommodative
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therapy with home reinforcement was more e'ective than the two
home-based therapies for the majority of outcomes (high-certainty
evidence). This was consistent for both the pair-wise comparisons
and the NMA. There was little evidence that pencil or target
push-ups, which are commonly recommended in routine clinical
practice, are an e'ective treatment for convergence insu'iciency
and in fact, may be no more e'ective than placebo therapy.
Despite the availability of further evidence on the e'ectiveness
of interventions for convergence insu'iciency in adults for this
update, imprecision of NMA estimates and heterogeneity in the
relative e'ects of interventions limited the applicability of the
evidence for the adult population. Furthermore, it was not possible
to determine the composite measures of treatment success in
adults.
Intuitively, one would expect that improving convergence function
may have a beneficial e'ect on reading performance and attention.
This was investigated as the primary outcome in one of the included
studies (CITT-ART 2019), which compared o'ice-based vergence/
accommodative therapy to o'ice-based placebo therapy in
children ages 9 to 14 with symptomatic convergence insu'iciency.
Despite demonstrating clinically significant improvements in
convergence function as shown for both the NPC and PFV,
office‑based vergence/accommodative therapy was found
to be no more e'ective than placebo therapy for improving
reading performance or attention aHer 16 weeks of treatment.
Although improved convergence ability could make reading and
school work performed at near more visually comfortable for
children with symptomatic convergence insu'iciency, the authors
concluded that eye care professionals should not suggest that such
treatment, on average, will lead to improvements on standardized
assessments of reading performance or attention aHer 16 weeks of
treatment.
None of the included trials reported on quality of life or performed a
health economic analysis of convergence insu'iciency treatments.
The monetary cost of o'ice-based vergence/accommodative
therapy is based on the therapy-visit fee and the number of
follow-up visits. Although the cost of this therapy is covered
by some medical insurance companies in the US and in some
publicly-funded healthcare systems outside the US, the cost of
the intervention is still a barrier to equitable access to treatment.
Eight of the included trials, randomizing 76% of study participants,
were conducted in the US and the remaining four studies in upper-
middle-income (Iran) or lower-middle-income (Egypt) countries.
None of the trials were conducted in low-income countries, so the
results of this review could be less applicable for these settings.
Ongoing studies
Three of the four ongoing studies are recruiting adults, and
the fourth study is recruiting both children and adults. If
these studies are completed, they may provide new data about
the e'ectiveness of non-surgical treatments for convergence
insu'iciency in adults. One study (NCT03593031) includes outcome
measures that have not been reported in the studies that form
the basis for this Cochrane Review. In addition, this ongoing study
is specifically designed to test potential hypotheses regarding
the underlying neural mechanisms of convergence insu'iciency
that might be improved aHer successful treatment with vergence/
accommodative therapy.
Quality of the evidence
In the children’s network, the overall certainty of evidence
was high for all comparisons involving o'ice-based vergence/
accommodative therapy and moderate-certainty to low-certainty
for comparisons between the two home-based interventions.
For almost all comparisons in the adult network, the certainty
of evidence was low (see 'Summary of findings' tables). We
downgraded the certainty of evidence primarily due to concerns
regarding within study bias, lack of precision in treatment e'ects,
and/or the existence of heterogeneity.
Four trials were included in the children’s network (CITT 2005b;
CITT 2008; CITT-ART 2019 and PEDIG 2016). We excluded Nehad
2018 from this network due to data errors and CITT 2005a tested
a disconnected intervention (prism reading glasses) that could not
be compared with other interventions in the network. The four
CITT trials (CITT 2005a; CITT 2005b; CITT 2008; CITT-ART 2019) were
graded at low risk of bias. PEDIG 2016 was judged to be at high risk
of attrition bias and Nehad 2018 was rated as unclear risk across all
bias domains. Two of the three trials that formed the adult network
(Aletaha 2018; Nabovati 2020) were also judged to have a high risk
of bias, which reduced our confidence in the estimates of treatment
e'ect from the adult network.
The clinical homogeneity in study populations, interventions,
and outcomes ensured that there were no systematic di'erences
between the available comparisons other than the treatments
being compared. The transitivity assumption was met for the
primary outcomes in both networks and there were no concerns
about indirectness.
Imprecision in the NMA estimates led to some concerns in
the children’s network and major concerns for a number of
comparisons in the young adult network, since the 95% confidence
interval crossed our pre-defined range of clinical equivalence.
Imprecision and heterogeneity were particularly evident for home-
based interventions in the children's network, which reduced the
certainty rating. Similarly, for many of the comparisons in the adult
network, there was evidence of inconsistency, which could have
led to di'erent conclusions on the relative e'ectiveness of the
interventions.
Potential biases in the review process
We took several measures to prevent potential bias in the
systematic review process, including having pre-specified eligibility
criteria, performing an extensive literature search, and having
two review authors working independently to evaluate eligibility,
assess risk of bias, and abstract data. We also contacted trial
investigators for additional information.
There is a potential conflict of interest as the lead author of this
review (Dr. Mitchell Scheiman) was the Principal Investigator for the
four CITT trials and served as Protocol Chair for the PEDIG trial. Two
other authors (SAC and MTK) also served as investigators in the CITT
trials and in the PEDIG trial. However, none of these investigators
participated in data abstraction and risk of bias assessment for the
trials in which they were involved.
Interventions for convergence insuiciency: a network meta-analysis (Review)









Cochrane Database of Systematic Reviews
Agreements and disagreements with other studies or
reviews
Findings from our systematic review are consistent with findings
from older narrative reviews on the same topic (Cacho 2009; Cooper
2012; Scheiman 2009) as well as a more recent narrative review
(Trieu 2018). None of these publications included a meta-analysis.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
This systematic review found high-certainty evidence that children
with symptomatic convergence insu'iciency who undergo o'ice-
based vergence/accommodative therapy are significantly more
likely to achieve treatment success than those who receive
placebo therapy, home-based pencil push-up treatment, or home-
based computer vergence/accommodative therapy. There was
no evidence of di'erence between home-based pencil push-ups
and home-based computer vergence/accommodative therapy, or
between either of the two home-based therapies and placebo
therapy, for treatment success in children. Base-in prism reading
glasses were found to be no more e'ective than placebo reading
glasses in children. Adherence issues may be one reason home-
based therapy is not as e'ective as o'ice-based therapy, but
closer monitoring of adherence to home-based treatment did not
lead to improved success rates. Evidence is less clear for the
adult population, although o'ice-based vergence/accommodative
therapy was more e'ective than home-based pencil push-ups for
improving the near point of convergence and positive fusional
vergence.
Implications for research
There are ‘unknowns’ related to research on non-surgical
interventions in the area of convergence insu'iciency. These
include determining answers to the following questions.
• Are certain o'ice-based vergence/accommodative therapy
procedures more e'ective than others for treating convergence
insu'iciency? Is there an o'ice-based therapy program that
would be equally as e'ective or perhaps even more e'ective,
but could be administered for a shorter duration or adapted for
home therapy?
• Are there di'erent home-based therapy combinations (e.g.
computer therapy combined with therapy procedures using
loose prisms or free-space fusion cards rather than pencil push-
ups alone) and/or a modified computer therapy program that
would be more e'ective than the combined computerized
therapy and pencil push-up approach (prescribed in PEDIG
2016), or equally as e'ective as o'ice-based therapy?
• Is it possible that a telemedicine or virtual format could improve
the e'ectiveness of home-based therapies?
• Could replacing some or all of the o'ice-based therapy visits
with telemedicine or virtual o'ice visits increase access and cost-
e'ectiveness while maintaining treatment e'ectiveness?
• Is there a better method of prescribing prism, such as based
on fixation disparity testing, that might be more e'ective in
reducing symptoms associated with convergence insu'iciency?
• The e'ect of successful treatment of symptomatic convergence
insu'iciency on health-related quality of life should be
investigated.
• Because insurance providers oHen do not pay for o'ice-based
therapy with home reinforcement, it would be helpful to
understand whether there are disparities in access to care for
particular populations. This would allow healthcare systems to
allocate appropriate resources.
• What is the cost utility of the various treatment interventions for
convergence insu'iciency?
• There is a need for more studies in adults, given the low-
certainty of evidence for treatment e'ectiveness.
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C H A R A C T E R I S T I C S   O F   S T U D I E S
Characteristics of included studies [ordered by study ID]
 
Study characteristics
Methods Study design: RCT
Number randomized: 84 (26 assigned to each group)
Unit of randomization: individual participant (convergence insufficiency is a binocular vision disorder)
Number analyzed: assumed 84 (100%)
Number of centers: 1
Date of first enrolment: January 2014
Length of treatment: unknown
Length of follow-up: planned: 6 months after completion of treatment; actual: 6 months after comple-
tion of treatment
Sample size estimation: not reported
Participants Country of recruitment: Iran
Mean age: 26.8 ± 8.3 (SD) years
Sex: 76% were female
Key inclusion criteria: participants aged between 15 and 35 years and had symptomatic convergence
insufficiency diagnosed using the Convergence Insufficiency Symptom Survey (CISS) ( > 16 points) ;
best‑corrected visual acuity 20/25 or better; exophoria at near at least 4 Δ greater than at dis-
tance; NPC > 6.0 cm break; insufficient near PFV (failing Sheard’s criterion or PFV ≤ 15 Δ base‑out).
Aletaha 2018 
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Key exclusion criteria: amblyopia (visual acuity worse than 20/30 in each eye); presence of manifest
strabismus; history of ocular surgery; any systemic disorder; anisometropia of more than 1.50 diopters
of myopia or hyperopia or significant refractive error; nystagmus; usage of medications that may im-
pair accommodation or convergence; ocular surface abnormalities or a history of ocular allergy; or
those who had previously been treated for CI.
Interventions Intervention regimen #1:home‑based vision therapy (HBVOT)
Participants were trained to perform the pencil push‑up procedure. This procedure is done by hold-
ing a pencil with 20/60 size letters at arm’s length in front of the eyes. The patient attempts to keep the
letters clear and pencil single while moving the pencil slowly towards his/her nose.";" Participants were
instructed to perform the pencil push‑up procedure for 15 min/day for 5 days/week.
Intervention regimen #2: office‑based vision orthoptic therapy (OBVOT)
OBVOT included 60 min of vision therapy using the major amblyoscope performed twice weekly with
additional home vision therapy (pencil push‑ups) prescribed for 15 min/day for 5 days/week (home
reinforcement).
Intervention regimen #3: augmented office‑based vision therapy (AOBVOT)
In-office therapy using the major amblyoscope & augmented vision therapy procedures having partic-
ipants view -3.00D over‑minus lenses (according to the patient’s refraction) and base‑out prism,
while the participant was performing a near task like reading a book.in addition to using the major am-
blyoscope. This therapy was performed for 60 min twice weekly with additional home reinforcement.
Outcomes Primary outcome: symptoms measured using the Convergence Insufficiency Symptom Survey (CISS)
(points); near point of convergence (cm); positive fusional vergence (∆)
Key secondary outcomes: primary and secondary outcomes were not distinguished
No harm was reported
Notes Funding sources: no funding
Subgroup analyses: none reported
Trial registration: NCT03431454
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk The patients were randomly allocated to one of the three groups by using
permuted‑block randomization: HBVOT, OBVOT, and AOBVOT
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding (performance
bias and detection bias)
Primary outcome
High risk Although the author says this was "single masked", the patients clearly knew
that they were in office-based or home-based therapy, so they were not
masked. The examiners were not masked because the authors state that the
therapists did the follow-up testing.
Blinding (performance
bias and detection bias)
Secondary outcomes
High risk The examiners were not masked because the authors state that the therapists




Unclear risk There is no flow chart showing the number of participants in the study at each
of the outcome assessments. None of the tables include the number of partici-
pants.
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Unclear risk See above.
Selective reporting (re-
porting bias)
Unclear risk Objective outcomes including PFV, NPC, exophoria at far and near distances,






Methods Study design: RCT
Number randomized: 60 (21 assigned to office-based therapy with supplemental home therapy; 20 as-
signed to home therapy group; and 19 assigned to control group)
Unit of randomization: individual participant (convergence insufficiency is a binocular vision disorder)
Number analyzed: 60 (100%)
Number of centers: 1
Date of first enrolment: not reported
Length of follow-up: planned: 26 weeks after initiation of treatment; actual: varied
Sample size estimation: not reported
Participants Country of recruitment: United States
Mean age: 63.9 years in the office-based therapy group, 61.1 in home therapy group, and 62.9 in control
group
Sex: 100% male
Key inclusion criteria: male adults aged 40 years with symptomatic convergence insufficiency; demon-
strated asthenopic symptoms; diplopia at near; headaches, eyestrain, or loss of concentration during
near work; and failed at least two of the four criteria for convergence insufficiency. Convergnece insuffi-
ciency criteria: NPC break worse than 10cm or recovery worse than 15cm; NPC with red lens to diplopia
worse than 20cm or recovery worse than 30cm; von Graefe near phoria of 8 ∆ exo or greater; near PFV <
15∆ or recovery measure,< 10 ∆.
Key exclusion criteria: patients with systemic neurologic disease; use of psychotropic medications that
might influence vergence or accommodation; constant or noncomitant strabismus; visual acuity poor-
er than 20/40 in either eye, or previous vision therapy.
Interventions Intervention regimen #1: office-based therapy with supplemental home therapy
Patients assigned to this group were scheduled for 24 weekly 45 minute office-based therapy sessions
(some patients discharged earlier, once their treatment was successfully concluded; some patients re-
quired somewhat longer treatment periods). The office therapy procedures typically used include se-
ries of eye movement procedures and binocular fusion procedures. Procedures were assigned for prac-
tice at home to supplement office therapy.
Intervention regimen #2: home therapy group
Patients were seen for one office visit for instruction on the home therapy procedures. The home thera-
py procedures include four-corner oculomotor calisthenic fixations; Brock string; eccentric circles base-
in and base-out; red-green lifesaver cards, base-in and base-out; and pointer-straw.
Birnbaum 1999 
Interventions for convergence insuiciency: a network meta-analysis (Review)









Cochrane Database of Systematic Reviews
Intervention regimen #3: control group
Patients were given a handout "Care of Your Eyes" (which was also given to patients in the two treat-
ment groups). This handout provided general information on ocular health, but provided no specific in-
formation relative to convergence insufficiency.
Outcomes Primary outcome: "Success" criterion met if participant passed both of following criteria: (1) as-
thenopia criteria (ability to read comfortably for at least 1 hour; no diplopia; and ability to read without
headaches, eyestrain, or loss of concentration at least 75% of the time) and (2) At least 3 of the 4 func-
tional criteria (adequate clinical measures for CNP; CNP with red lens, the near phoria, and base-out
vergence at near).
Secondary outcome: unclear
No harms were reported.
Notes Funding sources: none reported
Subgroup analyses: none reported
Trial registration: not available
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported.
Allocation concealment
(selection bias)
Unclear risk Not reported.
Blinding (performance
bias and detection bias)
Primary outcome
Unclear risk Not reported.
Blinding (performance
bias and detection bias)
Secondary outcomes








Low risk There was no loss to follow-up.
Selective reporting (re-
porting bias)





Methods Study design: RCT
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Number randomized: 72 (36 assigned to base-in prism reading glasses; 36 assigned to placebo reading
glasses)
Unit of randomization: individual participant (convergence insufficiency is a binocular vision disorder)
Number analyzed: 65 (90%) (31 of 36 assigned to base-in prism reading glasses; 34 of 36 assigned to
placebo reading glasses)
Number of centers: 9
Date of first enrolment: July 21, 2003
Length of follow-up: planned: 6 weeks after initiation of treatment; actual: 6 weeks after initiation of
treatment
Sample size estimation: all sample size calculations were performed using PASS 2000 software assum-
ing a two-sided test with α=0.05 and ß=0.10 (90% power). Preliminary data from CITT 2005b were used
to obtain estimates of variability to be used in the calculations. With 32 patients per group, the study
would have 90% power to find differences in the mean near point of convergence as small as 3.7 cm.
Participants Country of recruitment: United States
Mean age: 11.5 ± 2.3 (SD) years in the base-in prism reading glasses group; 11.0 ± 2.0 (SD) years in the
placebo reading glasses group
Sex: 63.9% were female in base-in prism reading glasses group; 47.2% were female in placebo reading
glasses group
Key inclusion criteria: age 9 to <18 years; best corrected visual acuity of 20/25 or better in both eyes at
distance and near; willingness to wear eyeglasses to correct refractive error, if necessary; exophoria at
near at least 4∆ greater than at far; insufficient positive fusional convergence at near (fails Sheard's cri-
terion); receded near point of convergence of ≥ 6 cm break; appreciation of at least 500 seconds of arc
on the forms part of the Randot Stereotest; Convergence Insufficiency Symptom Survey-V15 score ≥16;
informed consent and willingness to participate in the study and be randomized.
Key exclusion criteria: convergence insufficiency previously treated with prism, pencil push ups, or
office based vergence/accommodative therapy (no more than 2 months of treatment within the past
year); amblyopia; constant strabismus; history of strabismus surgery; anisometropia > 1.50 D (spheri-
cal equivalent) difference between eyes; previous refractive surgery; vertical heterophoria greater than
1∆; systemic diseases known to affect accommodation, vergence, and ocular motility such as multiple
sclerosis, Grave's thyroid disease, myasthenia gravis, diabetes, and Parkinsons disease; any ocular or
systemic medication known to affect accommodation or vergence; monocular accommodative ampli-
tude less than 4 D in either eye as measured by the push up method; manifest or latent nystagmus; at-
tention deficit hyperactivity disorder or learning disability diagnosis by parental report that, in the in-
vestigator's opinion, would interfere with treatment.
Interventions Intervention regimen #1: base-in prism reading glasses
Patients in this group received glasses that corrected for the patient’s refractive error, if necessary, and
base-in prism. The amount of prism was based on the minimum amount necessary to meet Sheard’s
criterion (prism to be prescribed = 2/3 phoria -1/3 compensating fusional vergence) with no less than
1 Δ prescribed. The amount of prism was rounded up to the nearest one-half prism diopter and split
equally between the two eyes if the magnitude exceeded 1 Δ. The patient was asked to wear these
glasses for all reading and near tasks requiring more than 5 minutes.
Intervention regimen #2: placebo reading glasses
Patients in this group received glasses that corrected their refractive error, or plano lenses were pre-
scribed for those who did not require a refractive correction. The patient was asked to wear these glass-
es for all reading and near tasks requiring more than 5 minutes.
Outcomes Primary outcome: Symptoms measured using Convergence Insufficiency Symptom Survey V-15 after 6
weeks of therapy.
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Key secondary outcomes: Clinical measures of near point of convergence and positive fusional ver-
gence at near after 6 weeks of wearing prescribed reading glasses .
No harms were reported.
Notes Funding sources: grants from the Pennsylvania and Ohio Lions.
Subgroup analyses: none reported
Trial registration: NCT00347581
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "The data coordinating center randomly assigned eligible patients with equal
probability to either base-in prism reading glasses or placebo reading glasses.
Randomization was accomplished with the study’s web site using a permuted
block design stratified by site."
Allocation concealment
(selection bias)
Low risk "Allocation to treatment group was achieved using a secure web site. Re-
searchers entered eligibility data on the study website after enrolment; after
verification of eligibility, the coordinating center provided the treatment group
assignment. (personal communication with the lead investigator)".
Blinding (performance
bias and detection bias)
Primary outcome
Low risk "Neither the patient nor the examiner performing testing at the outcome ex-
amination was aware of the treatment assignment. To prevent potential ex-
aminer unmasking by observation of the glasses, the study coordinator placed
Tarc 'N Stik reusable adhesive around the edges of the eyeglasses. The edges
of the lenses were therefore obscured, making it impossible for the examiner
to see the edge thickness of the lenses."
Blinding (performance
bias and detection bias)
Secondary outcomes




Unclear risk "Thirty one of the 36 patients (86%) assigned to receive base-in prism reading
glasses and 34 of the 36 (94%) assigned to placebo reading glasses completed
their 6 week outcome examination. There was no statistically significant differ-
ence in the percentage loss to follow up between the two treatment groups (P
= 0.43)."
"Statistical analyses techniques were employed which allowed for incomplete
data. No imputation or sensitivity analyses were performed (personal commu-




Unclear risk See above.
Selective reporting (re-
porting bias)





Methods Study design: RCT
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Number randomized: 47 (15 assigned to pencil push-ups; 17 assigned to vergence/accommodative
therapy; 15 assigned to placebo vergence/accommodative therapy)
Unit of randomization: individual participant (convergence insufficiency is a binocular vision disorder)
Number analyzed: 38 (81%); (11 of 15 assigned to pencil push-ups; 15 of 17 assigned to vergence/ac-
commodative therapy; 12 of 15 assigned to placebo vergence/accommodative therapy)
Number of centers: 6
Date of first enrolment: October 2000
Length of follow-up: planned: 12 weeks after initiation of treatment; actual: 12 weeks after initiation of
treatment
Sample size estimation: no formal sample size calculations were performed a priori because one goal
of this pilot trial was to estimate the variability of the outcome measure. At the study completion, us-
ing the observed variability in the Convergence Insufficiency Symptom Survey, with α=0.05, assum-
ing a 2-sided test, and assuming the post treatment mean of the most effective treatment group would
approximate the mean among patients with normal binocular vision, the mean for the placebo group
would decrease 20% from its baseline value, and the mean for the other treatment group would fall in
the middle of these two groups, the sample size of 47 yields a power of 92.8%.
Participants Country of recruitment: United States
Mean age: 11.2 ± 2.2 (SD) years
Sex: 57% were female
Key inclusion criteria: ages 9 to 18 years inclusive; best-corrected visual acuity of 20/25 OU at distance
and near; willingness to wear eyeglasses or contact lenses to correct refractive error, if necessary; ex-
ophoria at near at least 4 Δ greater than at far; insufficient positive fusional convergence (i.e., failing
Sheard's criterion or < 15 Δ break on positive fusional vergence testing using a prism bar); receded near
point of convergence of greater than or equal to 6 cm break; appreciation of at least 500s of arc on the
forms part of the Randot Stereotest; Convergence Insufficiency Symptom Survey-V13 (original 13-item
version) score > 9; informed consent and willingness to participate in the study and be randomized.
Key exclusion criteria: convergence insufficiency previously treated with pencil push-ups (no more
than 2 mo of treatment within the past year); convergence insufficiency previously treated with of-
fice-based vergence/accommodative therapy (no more than 2 mo of treatment within the past year);
amblyopia; constant strabismus; history of strabismus surgery; anisometropia > 1.50-D difference be-
tween eyes; prior refractive surgery; vertical heterophoria > 1 Δ; systemic diseases known to affect ac-
commodation, vergence, and ocular motility, such as multiple sclerosis, Graves thyroid disease, myas-
thenia gravis, diabetes, and Parkinson disease; any ocular or systemic medication known to affect ac-
commodation or vergence; monocular accommodative amplitude < 4 D in either eye as measured by
the Donder push-up method; manifest or latent nystagmus; attention-deficit/hyperactivity disorder or
learning disability diagnosis by parental report; household member or sibling already enrolled in the
CITT; any eye care professional, technician, medical student, or optometry student.
Interventions Intervention regimen #1: pencil push-ups
Patients in the pencil push-ups group were taught a pencil push-up procedure that included monitor-
ing for suppression. Patients were instructed to hold a pencil at arm’s length directly between their
eyes, and an index card, serving as a suppression control, was placed on the wall 6 to 8 feet away. Pa-
tients were instructed to look at the very tip of the sharpened pencil and to try and keep the pencil
point single while moving it toward their nose. If one of the cards in the background disappeared, pa-
tients were instructed to stop moving the pencil and blink their eyes until both cards were present. Pa-
tients were told to continue moving the pencil slowly toward their nose until it could no longer be kept
single and then to try and get the pencil point back into one. If patients were able to regain single vi-
sion, they were asked to continue moving the pencil closer to their nose. If patients could not get the
pencil back to one, they were instructed to start the procedure again. Patients were instructed to do
three sets of 20 pencil push-ups per day at home, 5 days per week for 12 weeks, and this treatment re-
CITT 2005b  (Continued)
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quired an average of 15 minutes per day. Prior to doing the procedure at home, children had to demon-
strate their understanding and ability to perform the procedure according to protocol.
Intervention regimen #2: office-based vergence/accommodative therapy
The vergence/accommodative therapy group received therapy administered by a trained therapist dur-
ing a weekly, 60-minute office visit, with additional procedures to be performed at home for 15 minutes
a day, five times per week for 12 weeks. The therapy procedures are provided in the publication. In ad-
dition, treatment procedures were practiced at home. During a typical office-based treatment session,
the patient practiced four to five procedures with constant supervision and guidance from the thera-
pist. There were no diagnostic tests performed during these sessions. The therapist followed a very de-
tailed and specific CITT protocol from the manual of procedures, which described the proper treatment
technique, amount of time the technique was to be used, expected performance, and criteria for end-
ing the procedure and advancing to a more difficult level.
Intervention regimen #3: placebo office-based vergence/accommodative therapy
Like the vergence/accommodative therapy group, the placebo vergence/accommodative therapy
group received therapy administered by a trained therapist during a 60-minute office visit and was pre-
scribed procedures to be performed at home for 15 minutes, five times per week for 12 weeks. The pro-
cedures for placebo vergence/accommodative therapy were designed to simulate real vergence/ac-
commodative therapy procedures without the expectation of affecting vergence, accommodation, or
saccadic function.
Outcomes Primary outcome: convergence insufficiency symptoms measured using Convergence Insufficiency
Symptom Survey V-15 after 12 weeks of therapy.
Key secondary outcomes: near point of convergence; positive fusional vergence at near.
No harms were reported.
Notes Funding sources: National Eye Insititute, National Insitutes of Health, Bethesda, Maryland, USA.
Subgroup analyses: none reported
Trial registration: NCT00347945
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "The data-coordinating center for the study, randomly assigned eligible pa-
tients with equal probability to either pencil push-ups, vergence/accommoda-
tive therapy, or placebo vergence/accommodative therapy. Randomization
was accomplished with the study's Web site using blocks of 6 so that the inves-
tigator could not predict the sequence of treatment assignments. To ensure
approximately equal numbers of patients in each treatment arm, randomiza-
tion was performed separately for each site."
Allocation concealment
(selection bias)
Low risk See above.
Blinding (performance
bias and detection bias)
Primary outcome
Low risk "At these follow-up visits, an examiner who was masked to the patient’s treat-
ment group administered the Convergence Insufficiency Symptom Survey
V-15, the cover test, and near point of convergence and positive fusional ver-
gence at near measurements."
Blinding (performance
bias and detection bias)
Secondary outcomes
Low risk See above.
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Unclear risk Completion rate was 88% (15/17) for the office-based vergence/accommoda-
tive therapy group, 80% (12/15) for the office-based placebo therapy group,
and 73% (11/15) for the pencil push-up group. "The completion rate was not
related to treatment assignment (P = .59). Of the nine patients not complet-
ing the primary outcome examination, four were lost to follow-up, two parents
decided after randomization that they preferred to have their children treat-
ed outside of the study, and three did not complete the outcome examination
within the visit window."
"There were no statistically significant or clinically relevant differences in de-
mographic or clinical measures at eligibility found between these patients and
those who completed the study within the treatment window."
"Statistical analyses techniques were employed which allowed for incomplete
data. No imputation or sensitivity analyses were performed (personal commu-




Unclear risk See above.
Selective reporting (re-
porting bias)





Methods Study design: RCT
Number randomized: 46 (17 assigned to pencil push-ups; 15 assigned to vergence/accommodative
therapy; 14 assigned to placebo vergence/accommodative therapy)
Unit of randomization: individual participant (convergence insufficiency is a binocular vision disorder)
Number analyzed: 40 (87%) (15 of 17 assigned to pencil push-ups; 12 of 15 assigned to vergence/ac-
commodative therapy; 13 of 14 assigned to placebo vergence/accommodative therapy)
Number of centers: 6
Date of first enrolment: November 2000
Length of follow-up: planned: 12 weeks after initiation of treatment; actual: 12 ± 2 weeks after initiation
of treatment
Sample size estimation: no formal sample size calculations were performed a priori because one goal
of this pilot trial was to estimate the variability of the outcome measure. At the study completion, us-
ing the observed variability in the Convergence Insufficiency Symptom Survey, with α=0.05, assuming
a 2-sided test, and assuming the post treatment mean of the most effective treatment group would ap-
proximate the mean among patients with normal binocular vision at 12 weeks, the mean for the place-
bo group would decrease 20% from its baseline value, and the mean for the other treatment group
would fall in the middle of these two groups, the sample size of 46 yielded a power of 99.6%.
Participants Country of recruitment: United States
Mean age: 24.4 ± 3.4 (SD) years in the pencil push-ups group; 23.7 ± 3.9 (SD) years in the vergence/ac-
commodative therapy group; 25.1 ± 3.5 (SD) years in the placebo vergence/accommodative therapy
group
CITT 2005c 
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Sex: 70.6% were female in the pencil push-ups group; 73.3% were female in the vergence/accommoda-
tive therapy group; 71.4% were female in the placebo vergence/accommodative therapy group
Key inclusion criteria: age 19 to 30 years; best corrected visual acuity of 20/25 or better in both eyes at
distance and near; willingness to wear eyeglasses or contact lenses to correct refractive error, if nec-
essary; exophoria at near at least 4 Δ greater than at far; insufficient positive fusional convergence at
near (i.e., failing Sheard's criterion or a positive fusional vergence measure or less than 15 Δ base-out
break); receded near point of convergence of ≥ 6 cm break; appreciation of at least 500 seconds of arc
on the forms part of the Randot Stereotest; Convergence Insufficiency Symptom Survey V-13 score ≥ 9;
informed consent and willingness to participate in the study and be randomized.
Key exclusion criteria: convergence insufficiency previously treated with pencil push ups, or of-
fice-based vergence/accommodative therapy (no more than 2 months of treatment within the past
year); amblyopia; constant strabismus; history of strabismus surgery; anisometropia > 1.50 D (spheri-
cal equivalent) difference between eyes; prior refractive surgery; vertical heterophoria > 1 Δ; systemic
diseases known to affect accommodation, vergence, and ocular motility such as multiple sclerosis,
Grave's thyroid disease, myasthenia gravis, diabetes, and Parkinsons disease; any ocular or systemic
medication known to affect accommodation or vergence; monocular accommodative amplitude less
than 4 D in either eye as measured by the push up method; manifest or latent nystagmus; household
member already enrolled in the CITT; any eye care professional, ophthalmic technician, medical stu-
dent, or optometry student.
Interventions Intervention regimen #1: pencil push-ups
Patients in the pencil push-ups group were taught a pencil push-up procedure that included monitor-
ing for suppression. Patients were instructed to hold a pencil at arm’s length directly between their
eyes, and an index card, serving as a suppression control, was placed on the wall 6 to 8 feet away. Pa-
tients were instructed to look at the very tip of the sharpened pencil and to try and keep the pencil
point single while moving it toward their nose. If one of the cards in the background disappeared, pa-
tients were instructed to stop moving the pencil and blink their eyes until both cards were present.
Patients were told to continue moving the pencil slowly toward their nose until it could no longer be
kept single and then to try and get the pencil point back into one. If patients were able to regain sin-
gle vision, they were asked to continue moving the pencil closer to their nose. If patients could not get
the pencil back to one, they were instructed to start the procedure again. Patients were instructed to
do three sets of 20 pencil push-ups per day at home, 5 days per week for 12 weeks, and this treatment
required an average of 15 minutes per day. Prior to doing the procedure at home, the patient had to
demonstrate their understanding and ability to perform the procedure according to protocol.
Intervention regimen #2: office-based vergence/accommodative therapy
The vergence/accommodative therapy group received therapy administered by a trained therapist dur-
ing a weekly, 60-minute office visit, with additional procedures to be performed at home for 15 minutes
a day, five times per week for 12 weeks. The items are listed elsewhere. In addition, treatment proce-
dures were practiced at home. During a typical office-based treatment session, the patient practiced
four to five procedures with constant supervision and guidance from the therapist. There were no diag-
nostic tests performed during these sessions. The therapist followed a very detailed and specific CITT
protocol from the manual of procedures, which described the proper treatment technique, amount of
time the technique was to be used, expected performance, and criteria for ending the procedure and
advancing to a more difficult level.
Intervention regimen #3: placebo office-based vergence/accommodative therapy
Like the vergence/accommodative therapy group, the placebo vergence/accommodative therapy
group received therapy administered by a trained therapist during a 60-minute office visit and was pre-
scribed procedures to be performed at home for 15 minutes, five times per week for 12 weeks. The pro-
cedures for placebo vergence/accommodative therapy were designed to simulate real vergence/ac-
commodative therapy procedures without the expectation of affecting vergence, accommodation, or
saccadic function.
Outcomes Primary outcome: symptoms measured using Convergence Insufficiency Symptom Survey V-15 after 12
weeks of therapy.
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Key secondary outcomes: near point of convergence, and positive fusional vergence at near.
No harms were reported.
Notes Funding sources: National Eye Insititute, National Insitutes of Health, Bethesda, Maryland, USA.
Subgroup analyses: none reported
Trial registration: NCT00347945
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "The data-coordinating center for the study, randomly assigned eligible pa-
tients with equal probability to either pencil push-ups, vergence/accommoda-
tive therapy, or placebo vergence/accommodative therapy. Randomization
was accomplished with the study's Web site using blocks of 6 so that the inves-
tigator could not predict the sequence of treatment assignments. To ensure
approximately equal numbers of patients in each treatment arm, randomiza-
tion was performed separately for each site."
Allocation concealment
(selection bias)
Low risk See above.
Blinding (performance
bias and detection bias)
Primary outcome
Low risk "Examiners were masked to the treatment assignment (personal communica-
tion with the lead investigator)."
Blinding (performance
bias and detection bias)
Secondary outcomes




Unclear risk "All results are reported for only those patients with data at the 12-week vis-
it.  Further analyses were performed after imputing outcome values for pa-
tients lost to follow-up. That is, the value at the last available examination was
used for each patient who did not complete the study. For 5/6 patients who did
not have outcome data at 12 weeks, the only data available were collected at
baseline. When differences in statistical analyses were found, the results from




Unclear risk See above.
Selective reporting (re-
porting bias)





Methods Study design: RCT
Number randomized: 221 (54 assigned to home-based pencil push-ups (HBPP); 53 assigned to home-
based computer vergence/accommodative therapy and pencil push-ups (HBCVAT+); 60 assigned to
office-based vergence/accommodative therapy with home reinforcement (OBVAT); 54 assigned to of-
fice-based placebo therapy with home reinforcement (OBPT))
CITT 2008 
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Unit of randomization: individual participant (convergence insufficiency is a binocular vision disorder)
Number analyzed: 219 (99%) (53 of 54 assigned to HBPP; 52 of 53 assigned HBCVAT+; 59 of 60 assigned
to OBVAT; 54 of 54 assigned to OBPT)
Number of centers: 9
Date of first enrolment: July 2005
Length of follow-up: planned: 12 weeks after initiation of treatment; actual: 12 weeks after initiation of
treatment
Sample size estimation: all sample size calculations were performed using PASS 2000 software and as-
suming a 2-sided test with 90% power. For a given outcome measure, the common standard deviation
(SD) obtained from the CITT pilot study was used as an estimate of variability. To control for multiple
comparisons (4 groups, with 2 compared at a time [6 pair-wise comparisons]), the α level used for de-
termining sample size was set at 0.0083 (0.05/6). The sample size of 52 children per group was based on
the required sample size for the 3 outcome variables and adjusted for a 10% loss to follow-up.
Participants Country of recruitment: United States
Mean age: 11.9 ± 2.2 (SD) years in the HBPP group; 11.6 ± 2.3 (SD) years in the HBCVAT+ group; 12.0 ± 2.6
(SD) years in the OBVAT group; 11.8 ± 2.2 (SD) years in the OBPT group
Sex: 50% were female in the HBPP group; 58% were female in the HBCVAT+ group; 68% were female in
the OBVAT group; 59% were female in the OBPT group
Key inclusion criteria: aged 9 to 17 years; exodeviation at near of at least 4 prism diopters greater than
at far; receded near point of convergence (NPC) break (≥ 6 cm); insufficient positive fusional vergence
at near (i.e., failing Sheard's criterion or < 15 Δ break on PFV); Convergence Insufficiency Symptom Sur-
vey (CISS) score ≥ 16; best-corrected visual acuity of 20/25 or better in both eyes at distance and near;
willingness to wear eyeglasses or contact lenses to correct refractive error, if necessary; appreciation of
at least 500 seconds of arc on the forms part of the Randot Stereotest.
Key exclusion criteria: convergence insufficiency previously treated with pencil push-up therapy (> 2
weeks of treatment), home- or office-based vergence/accommodative therapy; amblyopia; constant
strabismus; history of strabismus surgery; necessary refractive error correction worn for at least 2
weeks prior to eligibility determination; prior refractive surgery; vertical heterophoria > 1 Δ; systemic
diseases known to affect accommodation, vergence and ocular motility; accommodative amplitude <
5 D in either eye as measured by the Donders' push-up method; manifest or latent nystagmus; develop-
mental disability, mental retardation, attention-deficit/hyperactivity disorder, or a learning disability;
family or household member or sibling already enrolled in the CITT; family or household member of an
eye care professional, ophthalmic technician, ophthalmology or optometry resident, or optometry stu-
dent; convergence insufficiency secondary to acquired brain injury or any other neurological disorder.
Interventions Intervention regimen #1: home-based pencil push-ups
The pencil push-ups procedure involved using a pencil with 20/60 reduced Snellen letters and a white
index card placed in the background to provide a suppression check by using physiological diplopia
awareness. The goal of the procedure was to move the pencil to within 2 to 3 cm of the brow, just above
the nose on each push-up while trying to keep the target single and clear. Patients were instructed to
perform the pencil push-ups procedure 15 minutes per day, 5 days per week. They maintained home
therapy logs, recording the closest distance that they could maintain fusion after each 5 minutes of
therapy.
Intervention regimen #2: home-based computer vergence/accommodative therapy and pencil
push-ups
Patients in this group were taught to perform the pencil push-up procedure as well as procedures on
the Home Therapy System/Computerized Vergence System (HTS/CVS) computer software system
(Computer Orthoptics, Gold Canyon, Arizona). Using this program, they performed fusional vergence
and accommodative therapy procedures, including vergence base-in, vergence base-out, autoslide ver-
gence, and jump ductions vergence programs using random-dot stereopsis targets. The accommoda-
CITT 2008  (Continued)
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tive rock program was used for accommodative therapy. Much like a clinician would do at each fol-
low-up visit, this computer program automatically modified the therapy program after each session
based on the patient’s performance. Patients were instructed to do pencil push-ups 5 minutes per day,
5 days per week, and the HTS software program for 15 minutes per day, 5 days per week, and to save
their data on a disk provided by the study and to bring the disk to each follow-up visit.
Intervention regimen #3: office-based vergence/accommodative therapy with home reinforce-
ment
The OBVAT group received a weekly 60-minute in-office therapy visit with additional prescribed pro-
cedures to be performed at home for 15 minutes a day, 5 days per week. The therapy procedures are
described in detail elsewhere (CITT 2008). At each office-based therapy session, the patient performed
4 to 5 procedures with constant supervision and guidance from the therapist. There were no diagnos-
tic tests performed during these sessions. The therapist followed a detailed and specific protocol from
the CITT manual of procedures (http://optometry.osu.edu/research/CITT/4363.cfm); this document de-
scribes each procedure, amount of time procedure was performed, expected performance, and criteria
for ending the procedure and advancing to a more difficult level.
Intervention regimen #4: office-based placebo therapy with home reinforcement
Patients in the OBPT group received therapy during a weekly 60-minute office visit and were prescribed
procedures to be performed at home for 15 minutes per day, 5 days per week. The placebo therapy
program consisted of 16 in-office therapy procedures and 4 home therapy procedures, which were de-
signed to look like real vergence/accommodative therapy procedures yet not to stimulate vergence, ac-
commodation, or fine saccadic eye movement skills beyond normal daily visual activities. The thera-
pist followed a detailed protocol from the CITT manual of procedures. Five procedures were performed
during each office therapy visit and 2 procedures were assigned for home therapy each week. Objec-
tives and goals were established for each placebo procedure to simulate real therapy. For motivation-
al purposes, the therapist told the patient the objective of each procedure before beginning the tech-
nique.
Outcomes Primary outcome: convergence insufficiency symptoms measured using Convergence Insufficiency
Symptom Survey V-15 after 12 weeks of therapy. The CI symptoms was also measured at baseline, 4
and 8 weeks of therapy.
Key secondary outcomes: near point of convergence, and positive fusional vergence at near. The sec-
ondary outcomes were measured at baseline, 4, 8 and 12 weeks of therapy.
No harms were reported.
Notes Funding sources: National Eye Insititute, National Insitutes of Health, Bethesda, Maryland, USA.
Subgroup analyses: none reported
Trial registration: NCT00338611
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomization was achieved using a secure web site created and managed by
the data coordinating center. The web site generated the patient’s group as-
signment and assigned the patient a unique study identification number using
a pre-determined list generated by the data coordinating center. The random-
ization algorithm assigned patients to the four treatment groups with equal
probability using a randomized permuted block design so investigators could
not predict the sequence of treatment assignments. To ensure approximate-
ly equal numbers of patients in each treatment arm, randomization was per-
formed separately for each clinical site.
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Allocation concealment
(selection bias)
Low risk Access to the list was limited to the programmer and principal investigator of
the data coordinating center (personal communication with the lead investi-
gator).
Blinding (performance
bias and detection bias)
Primary outcome
Low risk The examiners responsible for obtaining the outcome measures were masked
to patient treatment assignment. 
None of the examiners felt that they could identify the patients’ group as-
signment at the 4 or 8 week masked examinations, and only one examiner
felt that he could identify the group assignment at outcome. One third of the
examiners responded that their patient was assigned to the OBVAT group,
24% responded that he/she was assigned to HBCVAT+, 21% said their patient
was assigned to HBPP, and 21% said their patient was assigned to the OBPT
group. Examiners, when asked to guess, were correct in identifying the pa-
tient’s group assignment only 34% of the time, which is less than is expected
by chance. There was low agreement between the actual group assignment
and the examiner’s guess of assigned treatment group (0.11, 95% confidence
interval, 0.04 to 0.20).
Blinding (performance
bias and detection bias)
Secondary outcomes




Unclear risk "Statistical analyses techniques were employed which allowed for incomplete
data. No imputation or sensitivity analyses were performed (personal commu-




Unclear risk See above.
Selective reporting (re-
porting bias)





Methods Study design: RCT
Number randomized: 311 (206 assigned to 16 weeks of office-based vergence/accommodative therapy
(OBVAT); 104 assigned to 16 weeks of office-based placebo therapy (OBPT); one participant was deter-
mined ineligible after randomization)
Unit of randomization: individual participant (convergence insufficiency is a binocular vision disorder)
Number analyzed: 302 (97%) (198 of 206 assigned to OBVAT; 104 of 104 assigned OBPT)
Number of centers: 9
Date of first enrolment: September 2014
Length of follow-up: planned: 16 weeks after initiation of treatment; actual: 16 weeks after initiation of
treatment
Sample size estimation:The CITT-ART's pre-planned sample size of 324 participants (216 in the OBVAT
group and 108 in the OBPT group) was chosen to provide sufficient power for the trial's primary aim of
determining whether treatment improved reading comprehension. This sample size provided > 95%
power with a two-sided type I error rate of 5% to detect treatment group differences in near point of
CITT-ART 2019 
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convergence of ≥ 4 cm, CISS score of ≥ 10 points, positive fusional vergence of ≥ 10 Δ, and vergence fa-
cility of ≥ 3 cpm.
Participants Country of recruitment: United States
Mean age: 10.8 ±1.5 (SD) years in the OBVAT group; 10.9 ± 1.4 (SD) years in the OBPT group
Sex: 58% were female in the OBVAT group; 46% were female in the OBPT group
Key inclusion criteria: Age 9 to 14 y; Grades 3 to 8; CISS score ≥ 16; Exophoria at near (40 cm) at least 4
Δ greater than at far (4 m); Receded near point of convergence of ≥ 6-cm break; Insufficient positive fu-
sional vergence at near (40 cm; i.e., failing Sheard's criterion or positive fusional vergence ≤ 15 Δ BO
break); Best-corrected distance (4 m) and near visual acuity (40 cm) of 20/25 or better in each eye; Ran-
dom-dot stereopsis appreciation of 500 seconds of arc or better (40 cm); Willing to wear refractive cor-
rection for uncorrected refractive errors (based on cycloplegic refraction within prior 6 mo; correction
must be worn for at least 2 weeks); Not wearing BI prism or a plus add at near for 2 weeks before study
enrolment and for duration of study; The timing of enrolment must allow a participant to be attending
school at both the baseline and the 16-week outcome examination; English is primary language spo-
ken at home, or the child is proficient in English as determined by the school; Parental permission to
contact the child's teacher(s) for study purposes; The parent and child understand the protocol and are
willing to accept randomization; The parent does not expect the child to start any new ADHD medicine
or change the dose of any currently taken ADHD medicine while the child is being treated in the study.
Key exclusion criteria: Constant strabismus at distance or near; Esophoria of ≥2Δ at distance; Verti-
cal heterophoria ≥ 2 Δ at distance or near; ≥ 2-line interocular difference in best-corrected distance
visual acuity; Monocular near point of accommodation > 20 cm (accommodative amplitude < 5 D) as
measured by push-up method; Manifest or latent nystagmus; Word reading subtest score < 80 on the
WRAT-4; KBIT-2 matrices subtest score < 70; History of strabismus, intraocular, or refractive surgery; CI
previously treated with any form of office-based vergence/accommodative therapy or home-based ver-
gence therapy (e.g., computerized vergence therapy); CI associated with head trauma or known dis-
ease of the brain; Diseases known to affect accommodation, vergence, or ocular motility such as multi-
ple sclerosis, Graves orbitopathy, myasthenia gravis, diabetes mellitus, Parkinson disease; Inability to
comprehend and/or perform any study-related test or procedure; Speech-language disorder (e.g., stut-
tering) that would interfere with interpretation of digital recordings of reading tests; Significant hear-
ing loss; Household member enrolled in the present CITT-ART or treated within the past 6 mo with any
form of office-based vergence/accommodative therapy or home-based vergence therapy (e.g., com-
puterized vergence therapy); Household member is an eye care professional, ophthalmic technician,
ophthalmology or optometry resident, or optometry student.
Interventions A 16-week program of weekly 60-minute in-office therapy specific to the assigned therapy (ver-
gence/accommodative or placebo) group was administered by study-certified optometrists, with four
to five therapy procedures administered in the office and 15 minutes of daily home therapy prescribed
for 5 days per week.
Intervention regimen #1: OBVAT
The OBVAT program was divided into 4 phases. Within each phase there are a number of categories
such as gross convergence, vergence, and accommodation.
Intervention regimen #2: OBPT
The OBPT program comprised pre-determined sequentially administered procedures designed to ap-
pear to be genuine therapy techniques but not to stimulate vergence, accommodation, or fine saccadic
eye movements beyond normal daily visual activities.
Outcomes Primary outcome: The change in the Wechsler Individual Achievement Test-III (WIAT-III) reading com-
prehension score as measured after the completion of 16 weeks of assigned treatment (OBVAT or
OBPT) .
Key secondary outcomes: change in the near point of convergence from baseline to 16 weeks; change
in positive fusional vergence from baseline to 16 weeks; change in the CISS score from baseline to 16
weeks; composite outcome measures. A successful outcome was a score of < 16 on the CISS, a normal
CITT-ART 2019  (Continued)
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NPC (6 cm), and a normal PFV (15 and passing the Sheard’s criterion). Improved was defined as a score
of < 16 or a 10-point decrease in the CISS score, and at least 1 of the following: normal NPC, an improve-
ment in NPC of more than 4 cm, normal PFV, or an increase in PFV of more than 10 Δ.
No harms were reported.
Notes Funding sources: National Eye Insititute, National Insitutes of Health, Bethesda, Maryland, USA.
Subgroup analyses: none reported
Trial registration: NCT02207517
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "Participants were randomly allocated using a permuted block (sizes of 3, 6,
and 9) design stratified by site and parent reported attention-deficit/hyper-
activity disorder status (yes/no) in a 2:1 allocation ratio to office-based ver-




Low risk See above
Blinding (performance
bias and detection bias)
Primary outcome
Low risk Protocol-specified follow-up visits were conducted by study-certified op-
tometrists and ophthalmologists masked to participants' treatment group af-
ter 4, 8, 12, and 16 weeks of therapy.
Examiners were asked if they became unmasked to the participant's treatment
group after each examination, and participants were asked upon completion
of their 16-week therapy program whether they thought they had received “re-
al” vergence/accommodative therapy or placebo therapy. None of the exam-
iners felt that they could identify the patients’ group assignment at the 4- or 8-
week masked examinations, and only 1 examiner felt that he could identify the
group assignment at outcome.
Blinding (performance
bias and detection bias)
Secondary outcomes




Low risk "The 16-week primary outcome visit was completed by 199 (96.6%) of the
206 participants in the vergence/accommodative group and by 100% of the
104 participants in the placebo group. Because only a few participants (n = 7)
missed their 16-week outcome visit, we believe that the probability of bias is




Low risk See above.
Selective reporting (re-
porting bias)
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Methods Study design: RCT
Number randomized: 60 (30 assigned to home-based pencil push-up therapy; 30 assigned to of-
fice-based therapy)
Unit of randomization: individual participant (convergence insufficiency is a binocular vision disorder)
Number analyzed: assumed 60 (100%, no loss to follow up reported and no sample sizes provided in re-
sults tables)
Number of centers: 1
Date of first enrolment: not reported
Length of follow-up: planned: 8 weeks; actual 8 weeks
Sample size estimation: not reported
Participants Country of recruitment: Iran
Mean age: 21.4 ± 0.9 (SD) years in home-based pencil push-up therapy group; 21.2 ± 0.9 (SD) years in of-
fice-based therapy group
Sex: 60% were female in both groups
Key inclusion criteria: Convergence Insufficiency Symptom Survey (CISS) score of ≥ 21 ; near exodevi-
ation which was at least 4 Δ more than distance; remote NPC (≥ 6 cm); insufficient near PFV (not meet-
ing Sheard's criterion, or break point < 15 Δ ); best corrected monocular VA of 20/25 or better at far and
near.
Key exclusion criteria: Constant strabismus; amblyopia; history of refractive surgery; vertical phoria of
1 prism diopter or more; presence of manifest or latent nystagmus; presence of eye disease; and/or a
history of strabismus surgery.
Interventions Intervention regimen #1: home-based pencil push-up therapy (PPT)
For home-based PPT, the participants held a pencil at 50 cm along the midline. They were instructed
to position themselves so that when they looked at the tip of the pencil, they were aware of diplopia
at far. A target such a clock on the wall behind the pencil was used to control suppression with use of
physiological diplopia. Next, the pencil was moved toward their eyes slowly, and the participants were
instructed to try to maintain fixation so that the target appeared as a single pencil. When they per-
ceived double vision of the target even with maximum effort, the pencil was moved back slowly until
they regained fusion. If suppression occurred and one of the physiologic diplopic images disappeared,
the participant was instructed to blink or shake the pencil as an anti-suppression technique. The sub-
jects performed this exercise at least three times a day for 5 minutes each time.
Intervention regimen #2: office-based vision therapy (OBVT)
The office-based therapy group was given exercises for improvement of vergence amplitude by prism,
vergence facility, accommodative amplitude, and facility. These exercises were performed two days
per week for 60 minutes. Participants had one minute break for each 5 minutes of therapy
Outcomes Primary outcome: symptoms measured using Convergence Insufficiency Symptom Survey (CISS), near
point of convergence, positive fusional vergence after 8 weeks of therapy
Key secondary outcomes: primary and secondary outcomes were not distinguished
No harms were reported
Notes Founding sources: Zahedan University of Medical Sciences
Subgroup analyses: none reported
Momeni Moghaddam 2015  (Continued)
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Trial registration: not available
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "Block randomization was used to divide subjects into two groups: Home-
based PPT and office-based therapy groups. Odd- numbered subjects were as-




Unclear risk Not reported.
Blinding (performance
bias and detection bias)
Primary outcome
Unclear risk Not reported
Blinding (performance
bias and detection bias)
Secondary outcomes








Low risk See above.
Selective reporting (re-
porting bias)





Methods Study design: RCT
Number randomized: 64 (32 assigned to prism reading glasses; 32 assigned to placebo reading glasses)
Unit of randomization: individual participant (convergence insufficiency is a binocular vision disorder)
Number analyzed: 61 (three participants lost to follow up)
Number of centers: 1
Date of first enrolment: November 2018
Length of follow-up: 12 weeks
Sample size estimation: not reported
Participants Country of recruitment: Iran
Mean age: 25.5 ± 5.5 (SD) years (no data presented by treatment group)
Sex: 44% were male (no data presented by treatment group)
Nabovati 2020 
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Key inclusion criteria: 18 to40 years old; convergence insufficiency diagnosed as 1) exophoria at near of
at least 4 prism diopters greater than at far, 2) receded near point of convergence (NPC) break (≥ 6 cm),
3) insufficient positive fusional vergence (PFV) at near, i.e. failing Sheard's criterion (near PFV less than
twice the near exophoria); 4) A normal monocular accommodative amplitude according to Hofstetter's
formula: measured monocular amplitude is above the minimum accommodative age-expected am-
plitude according to formula: 15 - 0.25 x (age); moderate to severe stages of CI based on the amount of
PFV measured at baseline; not a candidate for vision therapy due to financial issues, time limitation, or
lack of motivation.
Key exclusion criteria: best corrected visual acuity worse than 20/25 in either eye; constant strabismus;
latent or manifest nystagmus; previous treatment of CI in the past year; history of strabismus or refrac-
tive surgery; history of any intraocular surgery; use of ophthalmic or systemic drugs affecting binocular
vision or accommodation; and history of ocular trauma
Interventions Intervention regimen #1: prismatic spectacles
Non-emmetropic participants were instructed to wear the prescribed prism lenses only for near-work
activities lasting more than 15 minutes. If a participant was ametropic and required distance optical
correction, two pairs of glasses for near and far were prescribed and the prescribed prism was only ap-
plied in the near spectacles. The participant was instructed to use the distance glasses routinely and
wear the near spectacles for near-work activities like reading.
Intervention regimen #2: placebo spectacles
Non-emmetropic participants were instructed to wear the prescribed plano lenses only for near-work
activities lasting more than 15 minutes. If a participant was ametropic and required distance optical
correction, two similar pairs of glasses were prescribed. One pair was introduced as near glasses and
the participant was asked to use them for near-work activities.
Outcomes Primary outcome: Convergence Insufficiency Symptom Survey score
Secondary outcomes: near exophoria, near PFV, NPC, vergence facility, monocular accommodative
facility, accommodative response, negative relative accommodation, and accommodative conver-
gence/accommodation (AC/A) ratio
Notes Funding sources: not reported
Subgroup analyses: none reported
Trial registration: not available
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "The permuted block design approach was applied for the randomisation
process using Microsoft Excel software".
Allocation concealment
(selection bias)
Unclear risk "Each participant was first randomly assigned to either treatment (prism) or
control (placebo) groups by a coordinator outside the optometry examination
room."
Blinding (performance
bias and detection bias)
Primary outcome
High risk "The patients were masked to the group to which they were assigned." "Since
it was possible to identify the type of the assigned correction by the experi-
enced examiner, the examiner was not masked to the participant's group as-
signment at the outcome examination."
Blinding (performance
bias and detection bias)
Secondary outcomes
High risk "Since it was possible to identify the type of the assigned correction by the ex-
perienced examiner, the examiner was not masked to the participant's group
assignment at the outcome examination."
Nabovati 2020  (Continued)
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Low risk One participant (out of 32) and two participants (out of 32) were lost to follow




Low risk See above.
Selective reporting (re-
porting bias)
Unclear risk Although there was a trial registration number with the Iranian Registry of
Clinical Trials, we could not retrieve the registration information. All outcomes





Methods Study design: RCT
Number randomized: 113 (numbers assigned to each group were not reported)
Unit of randomization: not reported
Number analyzed: 102 (90%) (50 in office-based vision therapy with home therapy system group; 52 in
office-based vision therapy group)
Number of centers: 1
Date of first enrolment: May 2013
Length of follow-up: planned: 12 weeks; actual: 12 weeks
Sample size estimation: not reported
Participants Country of recruitment: Egypt
Mean age: 9.3 ± 1.2 (SD) years in office-based vision therapy with home therapy system group; 9.1 ± 1.6
(SD) years in office-based vision therapy group
Key inclusion criteria: an age of less than 16 years; exodeviation at near for at least 4 Δ more than at far;
a NPC break of ≥ 6 cm and insufficient PFV at near defined as failing Sheard’s criterion [PFV <twice the
near phoria] or minimum PFV of ≤ 15 Δ base-out blur or break; a CI Symptom Survey (CISS) score of ≥ 16
Key exclusion criteria: constant strabismus; past history of cover therapy; past-history of strabismus
surgery; lack of facilities for home computer
Interventions Intervention #1: office-based vision therapy (OBVT) with home therapy system (HTS)
In addition to OBVT, patients, using this program, performed fusional vergence therapy actions includ-
ing vergence base-in, vergence base-out, auto-slide vergence, and jump ductions vergence programs
by means of random dot stereopsis targets. The HTS software program was used for 20 minutes daily
for 6 days/week.
Intervention #2: office-based vision therapy (OBVT)
Patients had a weekly 60-minute in-office therapy. At each office-based therapy session, the patient
completed 4 to 5 procedures, such as the Brock string, binocular accommodative rock – flipper, stere-
ograms, vectograms, tranaglyphs, and stereoscopes under supervision from one of the authors
Nehad 2018 
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Outcomes Primary outcome: "success" defined by using symptoms measured with the Convergence Insufficien-
cy Symptom Survey, near point of convergence, and positive fusional vergence after 12 weeks of treat-
ment.
Key secondary outcomes: none reported
No harm was reported.
Notes Funding sources: no funding
Subgroup analyses: none reported
Trial registration: NCT03431454
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported.
Allocation concealment
(selection bias)
Unclear risk Not reported.
Blinding (performance
bias and detection bias)
Primary outcome
Unclear risk Not reported.
Blinding (performance
bias and detection bias)
Secondary outcomes








Unclear risk Not reported.
Selective reporting (re-
porting bias)





Methods Study design: RCT
Number randomized: 204 (75 assigned to home-based computer vergence; 85 assigned to home-based
near target push-up; 44 assigned to home-based placebo)
Unit of randomization: individual participant (convergence insufficiency is a binocular vision disorder)
Number analyzed: 169 (83%) (69 of 75 assigned to home-based computer vergence; 69 of 85 assigned
to home-based near target push-up; 31 of 44 assigned to home-based placebo)
Number of centers: 30
PEDIG 2016 
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Date of first enrolment: June 2012
Length of follow-up: planned: 12 weeks after initiation of treatment; actual: 12 weeks after initiation of
treatment
Sample size estimation: "The pre-planned sample size was 595 participants (238 participants in each
of the two active treatment groups, 119 participants in the placebo (HB-P) group) to have 90% power
to detect a treatment group difference for each of the two pairwise comparisons, HB-C versus HB-PU
and HB-C versus placebo, assuming true population success percentages of 30%, 15% and 10% for the
HB-C group, HB-PU group, and HB-P group, respectively, with a type I error rate of 2.5% per comparison
(5% overall) including adjustments for 3 planned interim analyses for futility and no more than 10%
loss to follow-up. The assumed success percentages were determined based on the Convergence In-
sufficiency Treatment Trial (CITT) and clinical expertise. Due to sample size considerations, it was not
feasible to compare the HB-PU group with the HB-P group as a primary outcome pairwise comparison
based on the assumed successful outcome percentages of 15% versus 10%."
Participants Country of recruitment: United States
Mean age: 12.2 ± 2.4 (SD) years in home-based computer vergence group; 12.6 ± 2.5 (SD) years in home-
based near target push-up group; 12.3 ± 2.3 (SD) years in home-based placebo group
Sex: 61% were female in home-based computer vergence group; 54% were female in home-based near
target push-up group; 59% were female in home-based placebo group
Key inclusion criteria: age 9 to <18 years; near exophoria 4 Δ or greater than at distance; reduced posi-
tive fusional vergence at near (PFV), defined as < 20 Δ mean PFV blur or failing Sheards’ criterion (mean
PFV measured less than twice the near phoria magnitude); mean near point of convergence (NPC) of ≥
6 cm break; symptomatic convergence insufficiency, defined as a Convergence Insufficiency Symptom
Survey (CISS) score of ≥ 16 points; best-corrected visual acuity of 20/25 or better in each eye at distance
and near; near random dot stereoacuity of at least 400 seconds of arc
Key exclusion criteria: ≥ 2 logMAR line difference in best-corrected visual acuity between the two eyes;
constant or intermittent exotropia at distance; constant exotropia at near; any esotropia at distance or
near; distance exophoria > 10 Δ; history of strabismus surgery; anisometropia ≥ 2.00 D in any meridian
between the eyes; prior intraocular or refractive surgery; primary vertical heterophoria greater than 1
Δ; diseases known to affect accommodation, vergence, and ocular motility such as multiple sclerosis,
Graves orbitopathy, myasthenia gravis, diabetes mellitus, or Parkinson disease; current use of any oc-
ular or systemic medication known to affect accommodation or vergence such as anti-anxiety agents;
near point of accommodation > 20 cm in the right eye; manifest or latent nystagmus evident clinically;
history of chronic headaches unrelated to reading activity
Interventions Intervention regimen #1: home-based computer vergence/accommodative therapy (HB-C)
The HB-C group was prescribed 15 minutes of active computer vergence/accommodative therapy
(CVAT) and 5 minutes of placebo flipper exercises.
Intervention regimen #2: home-based near target push-up therapy (HB-PU)
The HB-PU group was prescribed 15 minutes (in full or split into three 5-minute intervals) of a well-de-
fined near target push-up (NTP) procedure and 5 minutes of placebo CVAT.
Intervention regimen #3: home-based placebo treatment (HB-P)
The HB-P group was prescribed 15 minutes of placebo CVAT and 5 minutes of placebo flipper exercises.
Outcomes Primary outcome: successful outcome if meets at 12 weeks success criteria for all of the followings: (1)
Convergence Insufficiency Symptom Survey score of < 16 points and improvement of ≥ 9 points since
baseline; (2) mean near point of convergence (NPC) break of < 6 cm and a 12-week to baseline ratio of
< 0.763 for mean NPC break; (3) mean positive fusional vergence at near blur of >15 Δ and a 12-week to
baseline ratio of > 1.419 for mean PFV blur.
Key secondary outcomes: percentage of participants who met success criteria of the original compo-
nents of the primary outcome for both vergence measures (NPC and PFV). and percentage classified as
PEDIG 2016  (Continued)
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"improvers" (12-week CISS score improvement of ≥9 points since baseline; 12-week to baseline ratio of
> 0.763 for mean NPC break, and 12-week to baseline ratio of > 1.419 for mean PFV blur.
No harms were reported.
Notes Funding sources: National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA.
Subgroup analyses: none reported
Trial registration: NCT01515943
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk "Participants were randomly assigned (using a permutated block design strati-
fied by site) to 1 of 3 HB treatment groups (HB-C group, HB-PU group, and HB-




Low risk Allocation was adequately concealed (personal communication with the in-
vestigator).
Blinding (performance
bias and detection bias)
Primary outcome
Low risk "Participants were to remain masked to their treatment group until they com-
pleted the study."
"Placebo CVAT was similar to the active version except there was no specific
accommodation program and the procedures were designed not to stimulate
or exert any extra demand on the vergence system."
Blinding (performance
bias and detection bias)
Secondary outcomes
Low risk "With the exception of the cycloplegic refraction and stereoacuity testing, the
CISS and clinical testing were repeated at each follow-up examination by an
examiner who was masked to participants’ treatment group". "Examiners were




High risk Differential loss to follow-up [6(8%) participants in home-based computer
vergence group, 16(19%) in home-based near target push-up, and 13(30%) in





High risk See above.
Selective reporting (re-
porting bias)





Methods Study design: RCT
Number randomized: 7 (4 assigned to office-based vergence-accommodative therapy group; 3 as-
signed to control group)
Unit of randomization: individual participant (convergence insufficiency is a binocular vision disorder)
Widmer 2018 
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Number analyzed: 7 (100%)
Number of centers: 1
Date of first enrolment: not reported
Length of follow-up: planned: 12 weeks; actual: 12 weeks
Sample size estimation: not reported
Participants Country of recruitment: United States
Mean age: 26.1 ± 2.5 (SD) years
Sex: 86% were female
Key inclusion criteria: Participants aged 18 to 30 years; best-corrected visual acuity of 20/25 or better in
each eye at distance and near; exophoria at near ≥ 4 Δ greater than distance; receded near point of con-
vergence of ≥ 6 cm break; reduced positive fusional vergence (less than twice the near phoria OR < 15
Δ base-out blur, or break if no reported blur); CISS ≥ 21; accommodative amplitude ≥ 5 D; random-dot
stereopsis of at least 500 seconds of arc; cycloplegic refraction within the past 3 months; wearing any
needed refractive error correction for at least 2 weeks prior to eligibility; willingness to discontinue any
base-in prism or plus add wear; access to computer with Internet to perform the computerized home
therapy procedures; willingness to be randomized into either the active or placebo therapy; presump-
tive ability to successfully complete fMRI scanning; No previous treatment with vision therapy; not
personally or living with an eye-care professional, ophthalmology/optometry student/resident, oph-
thalmic technician, or employed in an eye care setting; no household member enrolled in any vergence
therapy study or currently completing vision therapy
Key exclusion criteria: Amblyopia; constant strabismus; vertical phoria >1 Δ; refractive surgery mani-
fest or latent nystagmus; refractive error (not corrected by contact lenses) beyond the range of the fM-
RI safe trial lens set; systemic diseases known to affect accommodation, vergence, or ocular motility;
current use of any medication known to affect accommodation, vergence, or ocular motility, history of
brain injury, neurological disease, or any condition that may be in conflict with obtaining normal fMRI
scans; pregnancy; presence of a pacemaker or any metallic implant that might be incompatible with
fMRI safety; developmental or learning disability that may interfere with treatment; leH-handed domi-
nance
Interventions Intervention #1: office-based vergence-accommodative therapy
"Each therapy visit consisted of 55 to 60 minutes of procedures, questions, and homework instructions.
Subjects were asked to perform home reinforcement procedures 15 minutes a day, 5 days a week.Of-
fice-based vergence-accommodative therapy subjects completed therapy designed to stress vergence
and accommodative abilities."
Intervention #2: office-based placebo therapy (No-vergence)
"...placebo subjects completed placebo therapy that did not involve vergence or accommodation be-
yond that involved in normal near tasks"
Outcomes Primary outcome: Changes in brain activation (using the blood oxygenation level–dependent signal
from fMRI) following office-based vergence/accommodative therapy versus placebo therapy
Key secondary outcomes: Success as defined as meeting all three of the following criteria: Convergence
Insufficiency Symptom Survey (CISS) score < 21 points, normal near point of convergence (< 6 cm), and
normal positive fusional vergence (> 15 Δ base-out and at least twice the near phoria) after 12 weeks of
therapy.
No harms were reported.
Notes Funding sources: Beta Sigma Kappa-College of Optometristsin Vision Development Research Grant;
Wright State University Research Initiation Grant; Optometric Educators Incorporated; Ohio Lions Eye
Research Foundation Fellowship Program; Center for Cognitive and Behavioral Brian Imaging, Phychol-
Widmer 2018  (Continued)
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ogy Department, Ohio State University; Home Therapy Solutions, Gold Canyon, Arizona (home rein-
forcement therapy)
Subgroup analyses: none reported
Trial registration: not available
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk "After completion of the baseline functional magnetic resonance imaging
scan, each subject was randomized to 12 weeks of weekly office-based ver-
gence-accommodative therapy or office-based placebo therapy."
Allocation concealment
(selection bias)
Low risk Allocation was adequately concealed (personal communication with the in-
vestigator).
Blinding (performance
bias and detection bias)
Primary outcome
Low risk "After 12 weeks of therapy, an examiner masked to the subject's assigned
treatment group performed the primary outcome vision testing and functional
magnetic resonance imaging scans."
Blinding (performance
bias and detection bias)
Secondary outcomes
Low risk "After 12 weeks of therapy, an examiner masked to the subject's assigned
treatment group performed the primary outcome vision testing and functional








Low risk See above
Selective reporting (re-
porting bias)
Unclear risk No mention of pre-specified protocol or registration for verification.
Widmer 2018  (Continued)
CITT: Convergence Insu'iciency Treatment Trial; HBPP: Home-based pencil push-ups; HBCVAT+: Home-based computer vergence/
accommodative therapy and pencil push-ups; OBVAT: O'ice-based vergence/accommodative therapy with home reinforcement; OBPT:
O'ice-based placebo therapy with home reinforcement; RCT: Randomized controlled trial; SD: Standard deviation
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Al-Qurainy 1995 Not in patients with convergence insufficiency
Alvarez 2014 Not a RCT
Alvarez 2015 Not a RCT
Barnhardt 2012 INot an RCT, it is a secondary analysis of symptom data from the CITT 2008
Borsting 2016 Not a RCT
Bremond Gignac 2014 Not a RCT
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Study Reason for exclusion
Cooper 2009 Not a RCT
Daum 1986 Not a RCT
Daum 1987 Not in patients with convergence insufficiency
Dragomir 2001 Not a RCT
Farid 2018 Not intervention of interest
Frantz 1993 Not a RCT
Gaertner 2013 Not a RCT
Gall 1998 Not a RCT
Gallaway 2002 Not a RCT
Gallaway 2017 Not a RCT
Granet 2005 Not a RCT
Grisham 1996 Unclear how many patients were affected by convergence insufficiency
Harele 2006 Not a RCT
Hatt 2013 Not in patients with convergence insufficiency
Horan 2015 Not a RCT
Horwood 2014a Not in patients with convergence insufficiency
Horwood 2014b Not a RCT
Hu 2012 Not in patients with convergence insufficiency
Hussaindeen 2018 Not in patients with convergence insufficiency
ISRCTN77268814 Not intervention of interest
Josephson 2017 Not the interventions of interest
Kapoula 2015 Not a RCT
Kerkhoff 1994 Not a RCT
Kommerell 2002 Not a RCT
Lambert 2013 Not a RCT
Ludlam 1988 Not in patients with convergence insufficiency
McGregor 2014 Not a RCT
Mitchell 2005 Not a RCT
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Study Reason for exclusion
NCT00917982 Not in patients with convergence insufficiency
NCT01435876 Not a RCT
O'Leary 2006 Not a RCT
Pang 2012 Not in patients with convergence insufficiency
Radakovi 2012 Not a RCT
Ramsay 2014 Not in patients with convergence insufficiency
Rawstron 2005 Not a RCT
Rowe 2017 Not in patients with convergence insufficiency
Rucker 2017 Not a RCT
Rutstein 1988 Not in patients with convergence insufficiency
Salus 2018 Not a RCT
Santos 2018 Not a RCT
Scheiman 2017 Not a RCT
Scheiman 2018 Not a RCT
Shah 2016 Not a RCT
Singh 2017 Not a RCT
Singman 2014 Not a RCT
Sreenivasan 2015 Not a RCT
Stavis 2002 Not a RCT
Teitelbaum 2009 Not in patients with convergence insufficiency
Thiagarajan 2013 Not in patients with convergence insufficiency
Thiagarajan 2014 Not a RCT
Wang 2014 Not a RCT
Wang 2017 Not a RCT
Whitecross 2013 Not a RCT
Worrell 1971 Not a RCT
RCT: Randomized controlled trial
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Characteristics of ongoing studies [ordered by study ID]
 
Study name A randomized controlled trial to compare the efficacy of pencil push-up therapy with orthoptic
therapy in emmetropic patients of convergence insufficiency
Methods Study type: RCT, parallel group
Location: Dehradun, India
Number of centers: 1




1. Age 9 to 35 years
2. Emmetropic patients with unaided visual acuity 6/6 (20/20)
3. Convergence Insufficiency Symptom Survey score more than 16
4. Receded near point of convergence more than 7.5 cm
5. Exophoria at near that is at least 4 Δ greater than at distance
6. Insufficient positive fusional vergence at near (positive fusional vergence blur / break of more than
15 ∆ )
7. Willingness to participate in the study
Exclusion criteria:
1. Previously treated with orthoptic exercise or pencil push-up exercises
2. Constant strabismus
3. History of strabismus surgery
4. Prior refractive surgery
5. Vertical phoria > 1 Δ
6. Manifest and latent nystagmus
7. Systemic diseases known to affect accommodation, vergence and ocular motility such as graves
thyroid disease, diabetes, multiple sclerosis myasthenia gravis
Interventions Treatment groups:
1. Orthoptic therapy
2. Pencil push up
Outcomes Primary outcome:
Near point of convergence:
a. Any value less than 7.5 cm will be considered cured
b. Improvement of 4 cm or more from the baseline will be considered improved
Secondary outcomes:
Convergence Insufficiency Symptom Survey score
a. Convergence Insufficiency Symptom Survey score less than 16 points will be considered asymp-
tomatic
CTRI/2018/05/013560 
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b. Decrease of at least 10 or more points from the baseline will be considered improved
Starting date May, 2018
Contact information Dr. Anupam; +8475000188; dr.anupamsingh@gmail.com
Notes Funding: all India institute of medical sciences, Rishikesh




Study name Convergence insufficiency: improvement of the near point of convergence after Institute Freespace
Stereogram exercises
Methods Study type: RCT, parallel group
Location: Thun, Switzerland
Number of centers: NR (multicenter)




1. Gender: both, male and female
2. Minimum age: 18 Years
3. Maximum age: no maximum age
4. Enlarged near point of convergence (more than 10 cm)
Exclusion criteria:
Strabismus, nystagmus, neurological diseases
Interventions Treatment groups:
1. The treatment group who will be performing the Institute Free-Space Stereogramm exercises
2. The placebo group who will be performing placebo training that was developed for this study
Outcomes Primary outcome
Change of the near point of convergence after visual therapy.
Secondary outcomes
1. Positive fusional vergence in cm/m
2. Score of the Convergence Insufficiency Symptom Survey questionnaire to quantify symptomatol-
ogy
3. Mallett criteria and the Sheard's criteria in cm/m (prism diopters)
Starting date April, 2018
Contact information Mr. BSc optom Volkhard Schroth; +41629572605; volkhard.schroth@fhnw.ch
Notes Funding: Institutional budget, no external funding (budget of sponsor/PI)
DRKS00014187 
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Study name Neural mechanism of vision therapy for patients with convergence insufficiency
Methods Study type: RCT, parallel group
Location: New Jersey, United States
Number of centers: NR




18 to 35 years old
Diagnosis of symptomatic convergence insufficiency binocularly normal control
Exclusion criteria:
History of head trauma any systematic disease that can interfere with vergence or accommodation
such as multiple sclerosis
Interventions Treatment groups:
1. Office-based vergence/accommodative therapy
2. Office-based placebo therapy
Outcomes Primary outcome:
Disparity vergence response amplitude
Secondary outcomes:
NR
Starting date April 2014
Contact information Tara L Alvarez, 9735965272, tara.l.alvarez@njit.edu






Study name Effectiveness of ophthalmic physiotherapy versus home exercises in the convergence insufficiency
Methods Study type: RCT, parallel group
Location: Cascavel, Brazil
U1111-1194-7855 
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1. Age above 18 years old




2. Ocular diseases under treatment
3. Cognitive and behavioral changes
Interventions Treatment groups:
1. Participants of the ophthalmic physiotherapy group will be attended by 6 physiotherapy ses-
sions to the total, being performed twice a week, lasting 40 minutes.
2. Participants of the patient education will receive a manual with home exercises and will be guid-
ed to perform them for 6 sessions, twice a week, lasting 40 minutes.
Outcomes Primary outcome:




Contact information Marcelo Taglietti; +554532291558; marcelotaglietti@gmail.com
Notes Funding: Faculdade Assis Gurgacz
Conflict of interest: NR
U1111-1194-7855  (Continued)
RCT: randomized controlled trial; NR: not reported
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    Adolescent and adults aged 15 to 35 years
Birnbaum
1999
      ✓   ✓   ✓ Male adult ≥ 40 years
CITT 2005a         ✓   ✓   Children aged 9 to 18 years
CITT 2005b ✓     ✓       ✓ Children aged 9 to 18 years
CITT 2005c ✓     ✓       ✓ Young adults aged 19 to 30 years
CITT 2008 ✓ ✓(and
pencil
  ✓       ✓ Children aged 9 to 17 years















































































































































CITT-ART 2019       ✓       ✓ Children aged 9 to 14 years









✓   ✓           University students (mean age
21.3 ± 0.9 years)
Nabovati 2020         ✓   ✓   Young adults aged 18-38 years
Nehad 2018     ✓ ✓         Children < 16 years
Widmer 2018       ✓       ✓ Young adults aged 18 to 30 years























































































































therapy with home reinforcement
2 0.32 (0.19,
0.56); - (one tri-
al only for this
composite out-
come)
0.12 (0.03, 0.59); -



































- (one trial on-


































therapy with home reinforcement
1 0.47 (0.30,
0.76); -



















Table 2.   Pairwise meta-analysis or individual study results: children 
CI: confidence interval; CISS: Convergence Insu'iciency Symptom Survey; MD: mean di'erence; NPC: near point of convergence; PFV:
positive fusional vergence; RCT: randomized controlled trial; RR: risk ratio
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3.1 4.41 (1.26, 15.38); low-certainty evi-
dence















2.5 5.12 (2.01, 13.07); moderate-certainty
evidence
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Table 3.   Network meta-analysis results: children 
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therapy with home reinforcement
     
















Table 3.   Network meta-analysis results: children  (Continued)
CI: confidence interval; CISS: Convergence Insu'iciency Symptom Survey; MD: mean di'erence; NPC: near point of convergence; PFV:
positive fusional vergence; RR: risk ratio
Values in cells equal improvement (or risk) in column-defining intervention, minus (or divided by) improvement (or risk) in row-defining
intervention; a MD greater than zero or a RR greater than 1 indicates greater improvement in column-defining intervention. We used the
Confidence in Network Meta-Analysis (CINeMA) framework for evaluating the certainty of evidence for our primary outcome of 'treatment






in NPC (MD with
95% CI); I2
Improvement in




with 95% CI); I2
Office-based vergence/accommodative therapy alone
vs
Office-based vergence/accommodative therapy with
home reinforcement




0.20 (-2.84, 3.24); -



























Table 4.   Pairwise meta-analysis or individual study results: adults 
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Office-based vergence/accommodative therapy with
home reinforcement
Base-in prism reading glasses
vs
Placebo intervention
1 0.4 (-1.9, 2.7)*; - 0.0 (-1.3, 1.2)*; - -8.9 (-11.6, -6.3)*; -
Table 4.   Pairwise meta-analysis or individual study results: adults  (Continued)
CI: confidence interval; CISS: Convergence Insu'iciency Symptom Survey; MD: mean di'erence; NPC: near point of convergence; PFV:
positive fusional vergence; RCT: randomized controlled trial









tive therapy with home reinforcement
     
1.5 -0.90 (2.03, -3.83) Office-based vergence/accom-
modative therapy alone
   











tive therapy with home reinforcement
     
2.0 3.80 (14.75, -7.15) Office-based vergence/accom-
modative therapy alone
   











tive therapy with home reinforcement
     











Table 5.   Network meta-analysis results: adults 
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2.9 3.03 (-6.33, 12.39) 3.23 (-6.61, 13.07) -1.46 (-10.77, 7.85) Placebo
interven-
tion
Table 5.   Network meta-analysis results: adults  (Continued)
CI: confidence interval; CISS: Convergence Insu'iciency Symptom Survey; MD: mean di'erence; NPC: near point of convergence; PFV:
positive fusional vergence
Values in cells equal improvement in column-defining intervention, minus improvement in row-defining intervention; a MD greater than
zero indicates greater improvement in column-defining intervention.
 
 
  Adherence determination Types of therapy




























CITT 2005b I, L 73% 92% 73% - -
CITT 2005c I, L 50% 69% 87% - -
CITT 2008 I, L, C 91% 87% 85% 67% -
CITT-ART
2019
I, L, C 64% 76% - - -
PEDIG 2016
bc
I, C - - 49% 68% 52%
Table 6.   Home therapy: Proportion of participants with estimated adherence of ≥ 75% 
a Electronic data from computer therapy prescribed as a component of home therapy
b All three home therapies tested in PEDIG 2016 had a computer component to monitor home usage
c Study personnel estimated proportion of participants with average compliance of > 75% for ≥ 5 days/week for the primary therapy
 
 
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
#1 MeSH descriptor: [Ocular Motility Disorders] explode all trees
#2 MeSH descriptor: [Convergence, Ocular] explode all trees
#3 MeSH descriptor: [Accommodation, Ocular] explode all trees
#4 MeSH descriptor: [Vision, Binocular] explode all trees
#5 MeSH descriptor: [Exotropia] explode all trees
#6 (Convergence near/3 insu'icienc*)





#12 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11
#13 prism*
#14 (pencil* near/2 push*)
#15 MeSH descriptor: [Orthoptics] explode all trees
Interventions for convergence insuiciency: a network meta-analysis (Review)









Cochrane Database of Systematic Reviews
#16 orthoptic*
#17 ((exercise* or therap* or treat*) near/10 home*)
#18 ((exercise* or therap* or treat*) near/10 o'ice*)
#19 (HBPP or HBCVAT* or OBVAT or OBPT)




#24 MeSH descriptor: [Eyeglasses] explode all trees
#25 (Eyeglass* or spectacle* or eye glass* or glasses)
#26 MeSH descriptor: [Exercise Therapy] explode all trees
#27 MeSH descriptor: [Therapy, Computer-Assisted] explode all trees
#28 #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27
#29 #12 and #28
Appendix 2. MEDLINE search strategy
1. Randomized Controlled Trial.pt.
2. Controlled Clinical Trial.pt.






9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8
10. exp animals/ not humans.sh.
11. 9 not 10
12. exp Ocular Motility Disorders/
13. exp Convergence, Ocular/
14. exp Accommodation, Ocular/
15. exp Vision, Binocular/
16. exp Exotropia/
17. (Convergence adj3 insu'icienc*).tw.







25. (pencil* adj2 push*).tw.
26. exp Orthoptics/
27. orthoptic*.tw.
28. ((exercise* or therap* or treat*) adj10 home*).tw.
29. ((exercise* or therap* or treat*) adj10 o'ice*).tw.
30. (HBPP or HBCVAT* or OBVAT or OBPT).tw.





36. (Eyeglass* or spectacle* or eye glass* or glasses).tw.
37. exp Exercise Therapy/
38. exp Therapy, Computer-Assisted/
39. or/24-38
40. 11 and 23 and 39
The search filter for trials at the beginning of the MEDLINE strategy is from the published paper by Glanville 2006.
Appendix 3. Embase search strategy
#1 'randomized controlled trial'/exp
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#2 'randomization'/exp
#3 'double blind procedure'/exp
#4 'single blind procedure'/exp
#5 random*:ab,ti
#6 #1 OR #2 OR #3 OR #4 OR #5
#7 'animal'/exp OR 'animal experiment'/exp
#8 'human'/exp
#9 #7 AND #8
#10 #7 NOT #9
#11 #6 NOT #10
#12 'clinical trial'/exp
#13 (clin* NEAR/3 trial*):ab,ti







#21 'latin square design'/exp
#22 #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21
#23 #22 NOT #10




#28 control*:ab,ti OR prospectiv*:ab,ti OR volunteer*:ab,ti
#29 #25 OR #26 OR #27 OR #28
#30 #29 NOT #10
#31 #30 NOT (#11 OR #23)
#32 #11 OR #24 OR #31





#38 (convergence NEAR/3 insu'icienc*):ab,ti





#44 #33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40 OR #41 OR #42 OR #43
#45 prism*:ab,ti
#46 (pencil* NEAR/2 push*):ab,ti
#47 'orthoptics'/exp
#48 orthoptic*:ab,ti
#49 ((exercise* OR therap* OR treat*) NEAR/10 home*):ab,ti
#50 ((exercise* OR therap* OR treat*) NEAR/10 o'ice*):ab,ti
#51 hbpp:ab,ti OR hbcvat*:ab,ti OR obvat:ab,ti OR obpt:ab,ti
#52 convergence:ab,ti AND (insu'icienc* NEAR/6 (exercise* OR therap* OR treat*)):ab,ti
#53 (vision NEXT/1 therap*):ab,ti
#54 (lens NEXT/1 therap*):ab,ti
#55 sterogram*:ab,ti
#56 'spectacles'/exp
#57 eyeglass*:ab,ti OR spectacle*:ab,ti OR 'eye glass':ab,ti OR 'eye glasses':ab,ti OR glasses:ab,ti
#58 'kinesiotherapy'/exp
#59 'computer assisted therapy'/exp
#60 #45 OR #46 OR #47 OR #48 OR #49 OR #50 OR #51 OR #52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58 OR #59
#61 #32 AND #44 AND #60
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Appendix 4. PubMed search strategy
1. ((randomized controlled trial[pt]) OR (controlled clinical trial[pt]) OR (randomised[tiab] OR randomized[tiab]) OR (placebo[tiab]) OR
(drug therapy[sh]) OR (randomly[tiab]) OR (trial[tiab]) OR (groups[tiab])) NOT (animals[mh] NOT humans[mh])
2. (Convergence[tw] AND insu'icienc*[tw]) NOT Medline[sb]
3. (Convergence[tw] AND disorder*[tw]) NOT Medline[sb]
4. Exodeviation*[tw] NOT Medline[sb]
5. Heterophoria*[tw] NOT Medline[sb]
6. Exotropi*[tw] NOT Medline[sb]
7. Exophori*[tw] NOT Medline[sb]
8. #2 OR #3 OR #4 OR #5 OR #6 OR #7
9. prism*[tw] NOT Medline[sb]
10. (pencil*[tw] AND push*[tw]) NOT Medline[sb]
11. orthoptic*[tw] NOT Medline[sb]
12. ((exercise*[tw] OR therap*[tw] OR treat*[tw]) AND home*[tw]) NOT Medline[sb]
13. ((exercise*[tw] OR therap*[tw] OR treat*[tw]) AND o'ice*[tw]) NOT Medline[sb]
14. (HBPP[tw] OR HBCVAT*[tw] OR OBVAT[tw] OR OBPT[tw]) NOT Medline[sb]
15. (convergence insu'icienc*[tw] AND (exercise*[tw] OR therap*[tw] OR treat*[tw])) NOT Medline[sb]
16. vision therap*[tw] NOT Medline[sb]
17. lens therap*[tw] NOT Medline[sb]
18. sterogram*[tw] NOT Medline[sb]
19. (Eyeglass*[tw] OR spectacle*[tw] OR eye glass*[tw] OR glasses[tw]) NOT Medline[sb]
20. #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19
21. #1 AND #8 AND #20
Appendix 5. metaRegister of Controlled Trials search strategy
Convergence insu'iciency OR Convergence disorder OR exodeviation OR Heterophoria OR Exotropia OR Exophoria
Appendix 6. ClinicalTrials.gov search strategy
Convergence insu'iciency OR Convergence disorder OR exodeviation OR Heterophoria OR Exotropia OR Exophoria
Appendix 7. ICTRP search strategy
Convergence insu'iciency OR Convergence disorder OR exodeviation OR Heterophoria OR Exotropia OR Exophoria
W H A T ' S   N E W
 
Date Event Description
8 September 2020 New citation required and conclusions
have changed
Issue 12, 2020: Seven new trials were included (Aletaha 2018;
CITT-ART 2019; Momeni Moghaddam 2015; Nabovati 2020; Ne-
had 2018; PEDIG 2016; Widmer 2018).
8 September 2020 New search has been performed Issue 12, 2020: New review authors added (MTK, JGL, LW); new
search performed; network meta-analysis conducted; certainty
of evidence graded.
 
H I S T O R Y
Protocol first published: Issue 4, 2007
Review first published: Issue 3, 2011
 
Date Event Description
19 August 2008 Amended Converted to new review format.
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D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
Adherence to treatment is reported as an ad hoc secondary outcome since the 2011 version of this Cochrane Review .
Cochrane methodology regarding assessments of the risk of bias in included studies has been modified. We updated the 'Assessment of
risk of bias in included studies' section of our 'Methods' to reflect updated methodological considerations since the 2011 version of the
review. We removed "intention-to-treat" as a domain for bias in the 2020 update.
In the 2020 update, we used NMA for data synthesis, introduced new primary outcomes, and graded the certainty of evidence, following
the CINeMA approach, for the primary outcomes. These changes were needed because pairwise comparisons do not answer the question
of the comparative e'ectiveness of all available interventions. The rationale for introducing new primary outcomes is described under
'Methods.'
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We also changed the title from non-surgical to all interventions because non-surgical implied that surgery is a viable option.
I N D E X   T E R M S
Medical Subject Headings (MeSH)
*Eyeglasses;  Ocular Motility Disorders  [*therapy];  Orthoptics  [*methods];  Randomized Controlled Trials as Topic
MeSH check words
Adult; Child; Humans
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